{"link":"http://blog.covance.com","html":"<!--<![endif]--><head>\n<meta charset=\"UTF-8\">\n<meta name=\"viewport\" content=\"width=device-width\">\n<title>Covance Blog - Sharing Innovation in Drug Development</title>\n<link rel=\"profile\" href=\"http://gmpg.org/xfn/11\">\n<link rel=\"stylesheet\" type=\"text/css\" media=\"all\" href=\"http://blog.covance.com/wp-content/themes/covance/style.css\">\n<link rel=\"pingback\" href=\"http://blog.covance.com/xmlrpc.php\">\n\n<!--[if lt IE 9]>\n<script src=\"http://blog.covance.com/wp-content/themes/covance/js/html5.js\" type=\"text/javascript\"></script>\n<![endif]-->\n\n<script type=\"text/javascript\" async=\"\" src=\"//assets.pinterest.com/js/pinit_main.js?0.7388315534653433\"></script><script type=\"text/javascript\" async=\"\" src=\"//img03.en25.com/i/elqCfg.min.js\"></script><script id=\"twitter-wjs\" src=\"http://platform.twitter.com/widgets.js\"></script><script type=\"text/javascript\">\nvar dataLayer = {\"pageType\":\"homepage\"};\n</script>\n<script type=\"text/javascript\" src=\"//assets.adobedtm.com/46a039608bea8fa7e28f747b5acd619eae39e89b/satelliteLib-d511f3e99f7bc347f8ec665f0483c333f915a422.js\"></script><script>\n  \nvar digitalData = {};  \n   \n// Set Notify Function \nfunction dtm_notify(text)\n{\n  _satellite.notify(text,1);\n\treturn true;\n}  \n  \n// Get URL,Path,Domain & Referrer  \n// Trim www and end slash\n  \nvar getURL = window.location.href;\nvar getRef = document.referrer;  \nvar getPath = window.location.host+window.location.pathname;\nvar getDomain = window.location.host;\nvar getPathName = window.location.pathname.toLowerCase();  \nvar trimPath = getDomain.replace(/.*?:\\/\\/www./g, \"\"); \nvar getUA = navigator.userAgent;  \n\n  \nif(!getRef){getRef=\"No Referrer\"};\ntrimPath = trimPath.replace(\"www.\", \"\");\n\ndtm_notify('DTM:Global Helper Script Loaded');\n  \nvar dir = trimPath.split('/');\nvar p1 = dir[1];\nif(!p1){trimPath = trimPath.substr(0, trimPath.lastIndexOf('/')) || trimPath;}\n   \n  \n// Get URL level data\n  \nfunction getBranch(level,d)\n{\n  var level;\n  var d;\n  var getPathName = window.location.pathname;\n  var dirArray = getPathName.split('/');\n  var thisDir = dirArray[level];\n  if(level ===\"length\"){\n \tthisDir=dirArray.length-2\n  }\n  if(d){\n  thisDir = '/'+thisDir+'/';\n  }\n  return thisDir;\n}\n  \n  \n// Get Defined Data Elements from UI\nfunction getDataElement(name)\n{\nvar getDE =_satellite.getVar(name);\nif(!getDE){\nvar getDE = \"Data Element Not Found\";\n}\nreturn getDE\n}  \n\nfunction sendEvent(trigger,meta)\n{\n if(!meta){meta=\"None\"}\n DDO.eventData = {\n \"action\":trigger,\n \"actionPage\":getPageName,\n \"actionURL\":getURL,\n \"meta\":meta  \n}  \n _satellite.track('sendEventDTM');\n}    \n  \nfunction sendEventDTM(trigger,metaOne,metaTwo,metaThree)\n{\n DDO.eventData = {\n \"action\":trigger,\n \"actionPage\":getPageName,\n \"actionURL\":getURL,\n \"metaOne\":metaOne,\n \"metaTwo\":metaTwo,\n \"metaThree\":metaThree,   \n}  \n _satellite.track('sendEventDTM');\n}  \n  \n\n  // Send Page View Function  \nfunction sendPageView(triggerName)\n{\n digitalData.eventData = {\n \"action\":'pageView',\n \"pageViewType\":triggerName,\n \"actionURL\":getURL\n}\n _satellite.track('sendPageView');\n}\n  \n \n</script>\n\n<meta name=\"adobe-dtm-wordpress\" content=\"true\">\n<!-- This site is optimized with the Yoast SEO plugin v4.2.1 - https://yoast.com/wordpress/plugins/seo/ -->\n<meta name=\"description\" content=\"Sharing Innovation in Drug Development\">\n<meta name=\"robots\" content=\"noodp\">\n<link rel=\"canonical\" href=\"http://blog.covance.com/\">\n<link rel=\"next\" href=\"http://blog.covance.com/page/2/\">\n<meta property=\"og:locale\" content=\"en_US\">\n<meta property=\"og:type\" content=\"website\">\n<meta property=\"og:title\" content=\"Covance Blog - Sharing Innovation in Drug Development\">\n<meta property=\"og:description\" content=\"Sharing Innovation in Drug Development\">\n<meta property=\"og:url\" content=\"http://blog.covance.com/\">\n<meta property=\"og:site_name\" content=\"Covance Blog\">\n<meta name=\"twitter:card\" content=\"summary\">\n<meta name=\"twitter:description\" content=\"Sharing Innovation in Drug Development\">\n<meta name=\"twitter:title\" content=\"Covance Blog - Sharing Innovation in Drug Development\">\n<meta name=\"twitter:site\" content=\"@covance\">\n<script type=\"application/ld+json\">{\"@context\":\"http:\\/\\/schema.org\",\"@type\":\"WebSite\",\"@id\":\"#website\",\"url\":\"http:\\/\\/blog.covance.com\\/\",\"name\":\"Covance Blog\",\"potentialAction\":{\"@type\":\"SearchAction\",\"target\":\"http:\\/\\/blog.covance.com\\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}}</script>\n<meta name=\"msvalidate.01\" content=\"A18349C1D4799939A1ACB3F1926CDB6F\">\n<meta name=\"google-site-verification\" content=\"_1_uNCh-9SBPJQXPEamQlMh1UYMzf77laBv_LFz_T2o\">\n<!-- / Yoast SEO plugin. -->\n\n<link rel=\"dns-prefetch\" href=\"//www.linksalpha.com\">\n<link rel=\"dns-prefetch\" href=\"//s0.wp.com\">\n<link rel=\"dns-prefetch\" href=\"//s.w.org\">\n<link rel=\"alternate\" type=\"application/rss+xml\" title=\"Covance Blog » Feed\" href=\"http://blog.covance.com/feed/\">\n<link rel=\"alternate\" type=\"application/rss+xml\" title=\"Covance Blog » Comments Feed\" href=\"http://blog.covance.com/comments/feed/\">\n\t\t<script type=\"text/javascript\">\n\t\t\twindow._wpemojiSettings = {\"baseUrl\":\"https:\\/\\/s.w.org\\/images\\/core\\/emoji\\/2.2.1\\/72x72\\/\",\"ext\":\".png\",\"svgUrl\":\"https:\\/\\/s.w.org\\/images\\/core\\/emoji\\/2.2.1\\/svg\\/\",\"svgExt\":\".svg\",\"source\":{\"concatemoji\":\"http:\\/\\/blog.covance.com\\/wp-includes\\/js\\/wp-emoji-release.min.js?ver=4.7.2\"}};\n\t\t\t!function(a,b,c){function d(a){var b,c,d,e,f=String.fromCharCode;if(!k||!k.fillText)return!1;switch(k.clearRect(0,0,j.width,j.height),k.textBaseline=\"top\",k.font=\"600 32px Arial\",a){case\"flag\":return k.fillText(f(55356,56826,55356,56819),0,0),!(j.toDataURL().length<3e3)&&(k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57331,65039,8205,55356,57096),0,0),b=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57331,55356,57096),0,0),c=j.toDataURL(),b!==c);case\"emoji4\":return k.fillText(f(55357,56425,55356,57341,8205,55357,56507),0,0),d=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55357,56425,55356,57341,55357,56507),0,0),e=j.toDataURL(),d!==e}return!1}function e(a){var c=b.createElement(\"script\");c.src=a,c.defer=c.type=\"text/javascript\",b.getElementsByTagName(\"head\")[0].appendChild(c)}var f,g,h,i,j=b.createElement(\"canvas\"),k=j.getContext&&j.getContext(\"2d\");for(i=Array(\"flag\",\"emoji4\"),c.supports={everything:!0,everythingExceptFlag:!0},h=0;h<i.length;h++)c.supports[i[h]]=d(i[h]),c.supports.everything=c.supports.everything&&c.supports[i[h]],\"flag\"!==i[h]&&(c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&c.supports[i[h]]);c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&!c.supports.flag,c.DOMReady=!1,c.readyCallback=function(){c.DOMReady=!0},c.supports.everything||(g=function(){c.readyCallback()},b.addEventListener?(b.addEventListener(\"DOMContentLoaded\",g,!1),a.addEventListener(\"load\",g,!1)):(a.attachEvent(\"onload\",g),b.attachEvent(\"onreadystatechange\",function(){\"complete\"===b.readyState&&c.readyCallback()})),f=c.source||{},f.concatemoji?e(f.concatemoji):f.wpemoji&&f.twemoji&&(e(f.twemoji),e(f.wpemoji)))}(window,document,window._wpemojiSettings);\n\t\t</script><script src=\"http://blog.covance.com/wp-includes/js/wp-emoji-release.min.js?ver=4.7.2\" type=\"text/javascript\" defer=\"\"></script>\n\t\t<style type=\"text/css\">\nimg.wp-smiley,\nimg.emoji {\n\tdisplay: inline !important;\n\tborder: none !important;\n\tbox-shadow: none !important;\n\theight: 1em !important;\n\twidth: 1em !important;\n\tmargin: 0 .07em !important;\n\tvertical-align: -0.1em !important;\n\tbackground: none !important;\n\tpadding: 0 !important;\n}\n</style>\n<link rel=\"stylesheet\" id=\"jquery.tipTip-css\" href=\"http://blog.covance.com/wp-content/plugins/wp-tooltip/js/tipTip.css?ver=1.3\" type=\"text/css\" media=\"all\">\n<link rel=\"stylesheet\" id=\"wp-tooltip-css\" href=\"http://blog.covance.com/wp-content/plugins/wp-tooltip/wp-tooltip.css?ver=1.0.0\" type=\"text/css\" media=\"all\">\n<link rel=\"stylesheet\" id=\"jetpack_css-css\" href=\"http://blog.covance.com/wp-content/plugins/jetpack/css/jetpack.css?ver=4.5\" type=\"text/css\" media=\"all\">\n<link rel=\"stylesheet\" id=\"ubermenu-basic-css\" href=\"http://blog.covance.com/wp-content/plugins/ubermenu/styles/basic.css?ver=2.0.1.0\" type=\"text/css\" media=\"all\">\n<link rel=\"stylesheet\" id=\"ubermenu-custom-css\" href=\"http://blog.covance.com/wp-content/plugins/ubermenu/styles/custom.css?ver=2.0.1.0\" type=\"text/css\" media=\"all\">\n<link rel=\"stylesheet\" id=\"lightboxStyle-css\" href=\"http://blog.covance.com/wp-content/plugins/lightbox-plus/css/shadowed/colorbox.min.css?ver=2.7.2\" type=\"text/css\" media=\"screen\">\n<script type=\"text/javascript\" src=\"//www.linksalpha.com/js/social.js?v=6.2&amp;ver=4.7.2\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-includes/js/jquery/jquery.js?ver=1.12.4\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/wp-tooltip/js/jquery.tipTip.minified.js?ver=1.3\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/wp-tooltip/js/wp-tooltip.js?ver=1.0.0\"></script>\n<link rel=\"https://api.w.org/\" href=\"http://blog.covance.com/wp-json/\">\n<link rel=\"EditURI\" type=\"application/rsd+xml\" title=\"RSD\" href=\"http://blog.covance.com/xmlrpc.php?rsd\">\n<link rel=\"wlwmanifest\" type=\"application/wlwmanifest+xml\" href=\"http://blog.covance.com/wp-includes/wlwmanifest.xml\"> \n<meta name=\"generator\" content=\"WordPress 4.7.2\">\n<link rel=\"shortlink\" href=\"http://wp.me/3q40m\">\n\n<!-- Facebook Open Graph metatags added by WordPress plugin. Get it at: http://www.linksalpha.com/widgets/buttons -->\n<meta property=\"og:site_name\" content=\"Covance Blog\">\n<meta property=\"og:title\" content=\"Covance Blog\">\n<meta property=\"og:url\" content=\"http://blog.covance.com\">\n<meta property=\"og:description\" content=\"Sharing Innovation in Drug Development\">\n<meta property=\"og:type\" content=\"blog\">\n<meta property=\"og:locale\" content=\"en_us\">\n<!-- End Facebook Open Graph metatags-->\n\n<!-- Google Plus metatags added by WordPress plugin. Get it at: http://www.linksalpha.com/widgets/buttons -->\n<meta itemprop=\"name\" content=\"Covance Blog\">\n<meta itemprop=\"description\" content=\"Sharing Innovation in Drug Development\">\n<!-- End Google Plus metatags-->\n<!--[if lt IE 9]><script src=\"http://ie7-js.googlecode.com/svn/version/2.1(beta4)/IE9.js\"></script><![endif]--><script type=\"text/javascript\">\n\twindow._wp_rp_static_base_url = 'https://rp.zemanta.com/static/';\n\twindow._wp_rp_wp_ajax_url = \"http://blog.covance.com/wp-admin/admin-ajax.php\";\n\twindow._wp_rp_plugin_version = '3.6.1';\n\twindow._wp_rp_post_id = '3089';\n\twindow._wp_rp_num_rel_posts = '6';\n\twindow._wp_rp_thumbnails = true;\n\twindow._wp_rp_post_title = 'Stepping+Up+the+Game%3A+Measles%2C+Mumps%2C+Rubella+and+Varicella+%28MMRV%29+Concomitant+Testing+Support+for+Vaccine+Evaluation';\n\twindow._wp_rp_post_tags = ['dengue', 'vaccines', 'immunotherapeutic+development', 'varicella', 'measles', 'zika', 'mmrv+testing', 'central+laboratory+services', 'zika+virus', 'mumps', 'chikungunya', 'rubella', 'covance', 'vaccine+development', 'clinical+development', 'drug+development', 'serum', 'vaccin', 'sampl', 'diseas', 'mmr', 'immun', 'clinic', 'review', 'test', 'game', 'world', 'measl', 'fda', 'pediatr', 'alt'];\n</script>\n<link rel=\"stylesheet\" href=\"http://blog.covance.com/wp-content/plugins/related-posts/static/themes/vertical-m.css?version=3.6.1\">\n\n<link rel=\"dns-prefetch\" href=\"//v0.wordpress.com\">\n<style type=\"text/css\">img#wpstats{display:none}</style>\t<style type=\"text/css\">\n\t\t\t#site-title,\n\t\t#site-description {\n\t\t\tposition: absolute !important;\n\t\t\tclip: rect(1px 1px 1px 1px); /* IE6, IE7 */\n\t\t\tclip: rect(1px, 1px, 1px, 1px);\n\t\t}\n\t\t</style>\n\t<style type=\"text/css\" id=\"custom-background-css\">\nbody.custom-background { background-color: #e8e8e8; }\n</style>\n<script language=\"JavaScript\" src=\"www.covance.com/code/sfdc-options.js\" type=\"text/javascript\"></script>\n<script language=\"JavaScript\" src=\"www.covance.com/code/sfdc-therapeutic.js\" type=\"text/javascript\"></script>\n<script language=\"JavaScript\" src=\"www.covance.com/code/sfdc-alerts.js\" type=\"text/javascript\"></script>\n\n<style type=\"text/css\"></style><script src=\"http://assets.adobedtm.com/46a039608bea8fa7e28f747b5acd619eae39e89b/s-code-contents-42540acfe923140d806caaf421976cc38834a3ac.js\"></script><style id=\"linksalpha-Styles\">div.linksalpha_div,span.linksalpha_span{background:0 0!important;border-image:none!important;border-width:0!important;font-variant:normal!important;font-weight:400!important;height:auto!important;letter-spacing:normal!important;visibility:visible!important}div.linksalpha_div{border-radius:0!important;bottom:auto!important;box-shadow:none!important;box-sizing:content-box!important;clear:none!important;color:#fff!important;display:block!important;filter:none!important;float:none!important;font-family:Arial,Helvetica,sans-serif!important;font-size:12px!important;font-stretch:normal!important;font-style:normal!important;left:auto!important;line-height:12px!important;margin:0!important;mask:none!important;opacity:1!important;outline:0!important;padding:0!important;position:relative!important;text-decoration:none!important;text-indent:0!important;text-rendering:auto!important;text-shadow:none!important;text-transform:none!important;top:auto!important;transform:none!important;transition:none!important;white-space:normal!important;width:auto!important;word-spacing:normal!important;z-index:999999!important}input.linksalpha_input,span.linksalpha_span{color:#000!important;font-stretch:normal!important;z-index:999999!important;bottom:auto!important;box-shadow:none!important;box-sizing:content-box!important;float:none!important;filter:none!important;font-family:Arial,Helvetica,sans-serif!important;margin:0!important;mask:none!important;padding:0!important;text-rendering:auto!important;transform:none!important;transition:none!important;word-spacing:normal!important;left:auto!important;opacity:1!important;outline:0!important;top:auto!important;position:relative!important;text-decoration:none!important}span.linksalpha_span{border-radius:0!important;display:inline!important;font-size:12px!important;font-style:normal!important;line-height:12px!important;text-indent:0!important;text-shadow:none!important;text-transform:none!important;white-space:nowrap!important;width:auto!important}input.linksalpha_input{background-color:#fff!important;background-image:none!important;background-repeat:no-repeat!important;background-position:right center!important;background-size:11px!important;border:1px solid #BFBFBF!important;border-radius:0!important;display:none!important;font-size:11px!important;font-style:normal!important;font-variant:normal!important;font-weight:400!important;height:16px!important;letter-spacing:normal!important;line-height:11px!important;text-indent:0!important;text-shadow:none!important;text-transform:none!important;visibility:visible!important;width:100px!important}a.linksalpha_link,svg.linksalpha_svg{font-size:12px!important;font-style:normal!important;font-variant:normal!important;font-weight:400!important;letter-spacing:normal!important;text-indent:0!important;text-shadow:none!important;text-transform:none!important;visibility:visible!important;white-space:nowrap!important;cursor:pointer!important}a.linksalpha_link{background:0 0!important;border-radius:0!important;border-width:0!important;bottom:auto!important;box-shadow:none!important;box-sizing:content-box!important;color:#0A65BB!important;display:inline-block!important;float:none!important;filter:none!important;font-family:Arial,Helvetica,sans-serif!important;height:auto!important;left:auto!important;margin:0!important;mask:none!important;opacity:1!important;outline:0!important;padding:0!important;position:relative!important;text-decoration:none!important;text-rendering:auto!important;top:auto!important;transform:none!important;transition:none!important;width:auto!important;word-spacing:normal!important}div.linksalpha_app_3>a,div.linksalpha_app_3>span{border-radius:2px!important}#linksalpha_dialog_container *,div.linksalpha_container *,svg.linksalpha_svg{font-family:Arial,\"Helvetica Neue\",Helvetica,sans-serif!important}a.linksalpha_link:hover{left:auto!important;letter-spacing:normal!important;opacity:1!important;outline:0!important;text-decoration:none!important;text-underline-position:under!important;top:auto!important}a.linksalpha_link:focus{outline:0}svg.linksalpha_svg{color:#0a65bb!important;display:inline!important;fill:#fff!important;height:32px!important;line-height:12px!important;overflow-x:hidden!important;overflow-y:hidden!important;transform-origin:16px 16px!important;width:32px!important;word-spacing:0!important;x:0!important;y:0!important;pointer-events:none!important}div.linksalpha_app_3,div.linksalpha_app_4{white-space:normal!important;font-size:0!important}div.linksalpha_app_3>span{display:inline-block!important;margin-left:5px!important;vertical-align:top!important;color:#000!important;background-color:#ebebeb!important;position:relative!important}div.linksalpha_app_3>span::after{border-color:transparent #ebebeb transparent transparent!important;border-style:solid!important;border-width:5px 8px 5px 0!important;content:\"\"!important;display:block!important;height:0!important;left:-6px!important;position:absolute!important;top:16px!important;transform:rotate(360deg)!important;width:0!important}#linksalpha_dialog_container .linksalpha_dialog,#linksalpha_dialog_container .linksalpha_dialog_overlay{left:0!important;right:0!important;bottom:0!important;top:0!important;position:fixed!important}div.linksalpha_app_4>a,div.linksalpha_app_4>div,div.linksalpha_app_4>iframe,div.linksalpha_app_4>span{display:inline-block!important;vertical-align:middle!important;margin:0 6px 3px 0!important}#linksalpha_dialog_container.linksalpha_div{z-index:1000000!important}#linksalpha_dialog_container .linksalpha_dialog_overlay{background-color:gray!important;opacity:.7!important}#linksalpha_dialog_container .linksalpha_dialog_content_container{background-color:#fff!important;margin:40px auto!important;width:60%!important;border-radius:3px!important;overflow:hidden;max-width:650px}#linksalpha_dialog_container .linksalpha_dialog_header{background-color:#4E7AC7!important;clear:both!important;padding:10px!important;height:18px!important}#linksalpha_dialog_container .linksalpha_dialog_header_title{float:left!important;width:calc(100% - 36px)!important}#linksalpha_dialog_container .linksalpha_dialog_header_title span:last-of-type{white-space:nowrap!important;overflow:hidden!important;width:calc(100% - 80px)!important;text-overflow:ellipsis!important;display:inline-block!important}#linksalpha_dialog_container .linksalpha_dialog_header_title,#linksalpha_dialog_container .linksalpha_dialog_header_title span{font-weight:700!important;color:#fff!important;font-size:14px!important;vertical-align:middle!important}#linksalpha_dialog_container .la_icon{background-color:#e74c3c!important;display:inline-block!important;height:14px!important;width:14px!important;padding:2px!important;border-radius:2px!important}#linksalpha_dialog_container .la_icon svg{width:100%!important;height:100%!important}#linksalpha_dialog_container .linksalpha_dialog_header_actions{float:right!important;color:#f0f0f0!important;text-align:right!important;cursor:pointer!important;font-size:14px!important;padding:3px 0!important}#linksalpha_dialog_container .linksalpha_dialog_header_actions:hover{color:#fff!important}#linksalpha_dialog_container .linksalpha_dialog_search_container{padding:7px 12px!important;border-bottom:1px solid #f0f0f0!important}#linksalpha_dialog_container #linksalpha_dialog_networks_container{overflow-y:auto!important;padding:10px!important;height:calc(100% - 120px)!important;max-height:255px!important;-webkit-overflow-scrolling:touch!important}#linksalpha_dialog_container .linksalpha_dialog_icon{display:inline-block!important;padding:10px!important;box-sizing:border-box!important;width:33%!important;border-radius:3px!important}#linksalpha_dialog_container .linksalpha_dialog_icon:hover{background-color:#f0f0f0!important}#linksalpha_dialog_container .linksalpha_dialog_icon>span{display:inline-block;vertical-align:middle;border-radius:2px!important}#linksalpha_dialog_container .linksalpha_dialog_icon svg{border-radius:2px!important}#linksalpha_dialog_container .linksalpha_dialog_icon>span:last-of-type{padding-left:5px!important;color:#4E7AC7!important;font-size:13px!important}#linksalpha_dialog_container .linksalpha_dialog_icon:hover>span:last-of-type{color:#2f2f2f!important}#linksalpha_dialog_container .linksalpha_dialog_footer{padding:10px!important;color:#5f5f5f!important;border-top:1px solid #dcdcd8;text-align:center!important}#linksalpha_dialog_container .linksalpha_dialog_footer a{text-decoration:none!important;color:#4E7AC7!important}#linksalpha_dialog_container .linksalpha_input{display:block!important;width:100%!important;max-width:100%!important;height:28px!important;border-radius:3px!important;border:1px solid #dcdcd8!important;padding:2px!important;box-sizing:border-box!important;font-size:13px!important;background-color:#f0f0f0!important}#linksalpha_dialog_container .linksalpha_input:focus{background-color:#fff!important;border-color:#BFBFBF!important}@media only screen and (min-width:980px){.linksalpha_icon_sms,.linksalpha_icon_viber,.linksalpha_icon_whatsapp,div.linksalpha_container .linksalpha_icon_sms,div.linksalpha_container .linksalpha_icon_viber,div.linksalpha_container .linksalpha_icon_whatsapp{display:none!important}}@media only screen and (max-width:980px){#linksalpha_dialog_container .linksalpha_dialog_content_container{margin:0 auto!important;width:100%!important;height:100%!important;border-radius:0!important;max-width:100%!important}#linksalpha_dialog_container .linksalpha_dialog_icon{display:block!important;padding:5px 10px!important;width:100%!important}#linksalpha_dialog_container #linksalpha_dialog_networks_container{padding:5px 0!important;max-height:100%!important;box-sizing:border-box!important}#linksalpha_dialog_container .linksalpha_dialog_search_container{padding:7px 10px!important}#linksalpha_dialog_container .linksalpha_dialog_footer{position:fixed!important;bottom:0!important;left:0!important;width:100%!important}div.linksalpha_app_1,div.linksalpha_app_2{display:none!important}}div.linksalpha_mobile_sharing_toolbar_container{display:none!important}@media only screen and (max-width:980px){div.linksalpha_mobile_sharing_toolbar_container{display:block!important;width:100%!important;position:fixed!important;left:0!important;box-sizing:border-box!important;background-color:#f0f0f0!important;border-top:1px solid #dcdcd8!important}div.linksalpha_mobile_sharing_toolbar_container div{text-align:center!important;color:#3f3f3f!important;font-size:14px!important;padding:10px!important}div.linksalpha_mobile_sharing_toolbar_container .la_icon{background-color:#3F3F3F!important;display:inline-block!important;height:14px!important;width:14px!important;padding:2px!important;vertical-align:text-bottom!important;border-radius:2px!important}div.linksalpha_mobile_sharing_toolbar_container .la_icon svg{width:100%!important;height:100%!important}}div.linksalpha_app_7{display:none!important;font-size:0!important}@media only screen and (max-width:980px){div.linksalpha_app_7{display:block!important;position:fixed!important;left:0!important;padding:5px 0 0!important;box-sizing:border-box!important;width:100%!important;text-align:center!important}}div.linksalpha_container.linksalpha_app_5{white-space:normal!important;display:table!important;background-color:#f0f0f0!important;border-radius:3px!important}div.linksalpha_container.linksalpha_app_5>div.linksalpha_div{text-align:center!important;vertical-align:middle!important;display:table-cell!important}div.linksalpha_container.linksalpha_app_5>div.linksalpha_jumbo_lhs_container{vertical-align:middle!important;width:20%!important}div.linksalpha_container.linksalpha_app_5>div.linksalpha_jumbo_lhs_container>div{font-size:18px!important;text-align:center!important;color:#666!important;line-height:normal!important;font-weight:700!important}div.linksalpha_container.linksalpha_app_5>div.linksalpha_jumbo_lhs_container>div:last-of-type{font-size:16px!important;font-weight:400!important}div.linksalpha_container.linksalpha_app_5>div.linksalpha_jumbo_rhs_container{text-align:left!important;border-left:1px solid #dcdcd8!important;vertical-align:middle!important;padding-right:3px!important;padding-left:3px!important}div.linksalpha_container.linksalpha_app_5 a.linksalpha_link>span.linksalpha_span{display:inline-block!important;height:100%!important;color:#fff!important;text-decoration:none!important;vertical-align:top!important}div.linksalpha_container.linksalpha_app_5 a.linksalpha_link>span.linksalpha_span:last-of-type{margin-top:6px!important}div.linksalpha_container.linksalpha_app_5 .linksalpha_jumbo_rhs_container>a{border-radius:2px!important}@media only screen and (max-width:980px){div.linksalpha_container.linksalpha_app_5 a.linksalpha_link>span.linksalpha_span:last-of-type{display:none!important}}</style><script type=\"text/javascript\" charset=\"utf-8\" async=\"\" src=\"https://platform.twitter.com/js/timeline.9d3a88fb5aef75c60edbbe5208a9b931.js\"></script><style type=\"text/css\"> .PIN_1492933324309_embed_grid { \n  width: 100%;\n  max-width: 257px;\n  min-width: 140px;\n  display: inline-block;\n  box-shadow: inset 0 0 1px #000;\n  border-radius: 5px;\n  overflow: hidden;\n  font: 12px \"Helvetica Neue\", Helvetica, arial, sans-serif;\n  color: rgb(54, 54, 54);\n  box-sizing: border-box;\n  background: #fff;\n  cursor: pointer;\n  -webkit-font-smoothing: antialiased;\n}\n .PIN_1492933324309_embed_grid * { \n  display: block;\n  position: relative;\n  font: inherit;\n  cursor: inherit;\n  box-sizing: inherit;\n  margin: 0;\n  padding: 0;\n  text-align: left;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_hd { \n  height: 55px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_hd .PIN_1492933324309_img { \n  position: absolute;\n  top: 10px;\n  left: 10px;\n  height: 36px;\n  width: 36px;\n  border-radius: 3px;\n  background: transparent url () 0 0 no-repeat;\n  background-size: cover;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_hd .PIN_1492933324309_pinner { \n  white-space: nowrap;\n  overflow: hidden;\n  text-overflow: ellipsis;\n  width: 75%;\n  position: absolute;\n  top: 20px;\n  left: 56px;\n  font-size: 14px;\n  font-weight: bold;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_bd { \n  padding: 0 10px;\n  -moz-scrollbars: none;\n  -ms-overflow-style: none;\n  overflow-x: hidden;\n  overflow-y: auto;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_bd .PIN_1492933324309_ct { \n  width: 100%;\n  height: auto;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  display: inline-block;\n  width: 100%;\n  padding: 1px;\n  vertical-align: top;\n  min-width: 60px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col .PIN_1492933324309_img { \n  margin: 0;\n  display: inline-block;\n  width: 100%;\n  background: transparent url() 0 0 no-repeat;\n  background-size: cover;\n  box-shadow: inset 0 0 1px #000;\n  border-radius: 2px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft { \n  padding: 11px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button { \n  border-radius: 3px;\n  text-align: center;\n  box-shadow: inset 0 0 1px #888;\n  background-color: #efefef;\n  position: relative;\n  display: block;\n  overflow: hidden;\n  height: 33px;\n  width: 100%;\n  min-width: 70px;\n  padding: 0 3px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button .PIN_1492933324309_label { \n  position: absolute;\n  left: 0;\n  width: 100%;\n  text-align: center;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button .PIN_1492933324309_label.PIN_1492933324309_top { \n  top: 0;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button .PIN_1492933324309_label.PIN_1492933324309_bottom { \n  bottom: 0;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button .PIN_1492933324309_label .PIN_1492933324309_string { \n  white-space: pre;\n  color: #746d6a;\n  font-size: 13px;\n  font-weight: bold;\n  vertical-align: top;\n  display: inline-block;\n  height: 33px;\n  line-height: 33px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button .PIN_1492933324309_label .PIN_1492933324309_logo { \n  display: inline-block;\n  vertical-align: top;\n  height: 33px;\n  width: 65px;\n  background: transparent url(data:image/svg+xml;base64,<svg xmlns="http://www.w3.org/2000/svg" height="16px" width="64px" viewBox="0 0 64 16"><g><path d="M33.215,7.667 C33.888,7.667 34.122,8.075 34.122,8.562 C34.122,9.386 33.482,9.889 32.481,9.889 C32.124,9.889 31.625,9.804 31.329,9.704 C31.452,8.948 31.94,7.667 33.215,7.667 L33.215,7.667 Z M47.669,7.667 C48.284,7.667 48.571,8.075 48.571,8.562 C48.571,9.386 47.936,9.889 46.931,9.889 C46.572,9.889 46.07,9.804 45.772,9.704 C45.895,8.948 46.439,7.667 47.659,7.667 L47.669,7.667 Z M62.906,7.736 C63.111,7.736 63.245,7.65 63.286,7.454 C63.347,7.166 63.47,6.664 63.511,6.531 C63.552,6.356 63.45,6.223 63.255,6.223 L61.737,6.223 C61.84,5.782 62.271,4.367 62.271,3.444 C62.271,1.599 60.702,0.03 58.487,0.03 C55.975,0.03 54.344,1.711 54.344,4.08 C54.344,4.767 54.601,5.577 54.919,6.069 C54.785,6.059 54.642,6.054 54.508,6.054 C52.601,6.054 51.402,7.09 51.402,8.593 C51.402,10.008 52.509,10.559 53.565,10.92 C54.488,11.249 55.349,11.4 55.349,12.12 C55.349,12.612 54.878,12.899 53.955,12.899 C52.858,12.899 52.253,12.387 52.099,12.192 C52.201,12.11 52.355,11.915 52.355,11.595 C52.355,11.144 52.039,10.775 51.449,10.775 C50.948,10.775 50.526,11.185 50.419,11.718 C49.619,12.374 48.743,12.802 47.503,12.802 C46.283,12.802 45.647,12.166 45.647,10.813 C45.934,10.902 46.683,11.008 47.175,11.008 C49.246,11.008 50.651,10.064 50.651,8.184 C50.651,7.172 49.769,6.108 48.005,6.108 C45.692,6.108 44.399,7.575 43.832,9.184 L43.355,9.076 C43.489,8.717 43.577,8.301 43.577,7.845 C43.577,7.045 43.085,6.107 41.762,6.107 C40.845,6.107 39.974,6.708 39.37,7.61 L39.626,6.606 C39.664,6.452 39.599,6.283 39.359,6.283 L38.006,6.283 C37.814,6.283 37.678,6.354 37.62,6.57 L36.667,10.312 C36.39,11.43 34.913,12.814 33.057,12.814 C31.835,12.814 31.201,12.138 31.201,10.784 C31.522,10.912 32.235,11.02 32.726,11.02 C34.879,11.02 36.205,10.081 36.205,8.197 C36.205,7.187 35.313,6.124 33.56,6.124 C30.945,6.124 29.345,8.148 29.079,10.441 C28.966,11.394 28.156,12.703 27.284,12.703 C26.864,12.703 26.628,12.436 26.628,11.985 C26.628,11.595 26.901,10.631 27.202,9.432 C27.305,9.032 27.456,8.416 27.626,7.74 L29.051,7.74 C29.259,7.74 29.382,7.647 29.431,7.453 C29.498,7.165 29.622,6.673 29.656,6.54 C29.704,6.366 29.601,6.227 29.404,6.227 L28.009,6.227 L28.666,3.606 C28.727,3.346 28.508,3.196 28.281,3.244 C28.281,3.244 27.204,3.455 27.006,3.498 C26.804,3.539 26.647,3.646 26.575,3.939 L26.011,6.225 L24.904,6.225 C24.691,6.225 24.568,6.312 24.522,6.509 C24.453,6.792 24.327,7.288 24.293,7.422 C24.245,7.6 24.35,7.735 24.55,7.735 L25.645,7.735 C25.638,7.769 25.25,9.242 24.937,10.565 C24.789,11.204 24.293,12.691 23.481,12.691 C22.999,12.691 22.794,12.445 22.794,11.922 C22.794,11.096 23.606,9.031 23.606,8.093 C23.606,6.842 22.935,6.114 21.559,6.114 C20.693,6.114 19.795,6.678 19.414,7.171 C19.414,7.171 19.529,6.771 19.57,6.617 C19.612,6.453 19.529,6.292 19.314,6.292 L17.971,6.292 C17.684,6.292 17.609,6.446 17.567,6.612 L16.598,10.406 C16.275,11.657 15.503,12.703 14.68,12.703 C14.25,12.703 14.065,12.436 14.065,11.974 C14.065,11.585 14.313,10.621 14.619,9.421 C14.983,7.965 15.306,6.766 15.342,6.622 C15.388,6.444 15.307,6.288 15.075,6.288 L13.722,6.288 C13.476,6.288 13.388,6.414 13.338,6.595 C13.338,6.595 12.959,8.034 12.557,9.641 C12.27,10.806 11.942,11.993 11.942,12.549 C11.942,13.543 12.386,14.292 13.616,14.292 C14.559,14.292 15.308,13.81 15.882,13.202 L15.739,13.766 C15.687,13.957 15.749,14.125 15.967,14.125 L17.352,14.125 C17.593,14.125 17.685,14.027 17.736,13.817 L18.833,9.551 C19.103,8.451 19.777,7.726 20.73,7.726 C21.181,7.726 21.571,8.024 21.526,8.605 C21.475,9.244 20.706,11.538 20.706,12.545 C20.706,13.303 20.989,14.288 22.422,14.288 C23.396,14.288 24.114,13.816 24.637,13.211 C24.832,13.849 25.334,14.28 26.267,14.28 C27.816,14.28 28.749,13.36 29.302,12.438 C29.751,13.515 30.815,14.284 32.379,14.284 C33.968,14.284 35.204,13.61 36.076,12.697 L35.806,13.781 C35.755,13.973 35.841,14.125 36.067,14.125 L37.437,14.125 C37.621,14.125 37.757,14.028 37.806,13.83 C37.828,13.734 38.027,12.969 38.308,11.882 C38.842,9.801 39.703,7.642 40.993,7.642 C41.449,7.642 41.637,7.897 41.637,8.298 C41.637,8.487 41.581,8.649 41.534,8.739 C40.909,8.614 40.404,8.922 40.404,9.59 C40.404,10.027 40.863,10.423 41.481,10.423 C41.953,10.423 42.345,10.308 42.657,10.097 C42.954,10.159 43.262,10.225 43.58,10.297 C43.539,10.61 43.508,10.918 43.508,11.207 C43.508,12.879 44.769,14.297 46.902,14.297 C48.584,14.297 49.65,13.733 50.665,12.898 C51.147,13.678 52.347,14.303 53.926,14.303 C56.09,14.303 57.32,13.175 57.32,11.688 C57.32,10.335 56.213,9.843 55.074,9.433 C54.152,9.094 53.372,8.92 53.372,8.264 C53.372,7.72 53.803,7.474 54.521,7.474 C54.992,7.474 55.341,7.577 55.536,7.628 C55.72,8.089 56.11,8.612 56.777,8.612 C57.335,8.612 57.587,8.171 57.587,7.761 C57.587,6.602 55.657,6.479 55.657,3.998 C55.657,2.45 56.533,1.178 58.343,1.178 C59.603,1.178 60.425,1.978 60.425,3.26 C60.425,4.316 59.779,6.213 59.779,6.213 L58.682,6.213 C58.472,6.213 58.347,6.295 58.299,6.49 L58.071,7.402 C58.027,7.577 58.128,7.71 58.327,7.71 L59.393,7.71 C59.617,7.749 58.286,12.45 58.286,12.529 C58.286,13.524 58.848,14.272 60.075,14.272 C61.808,14.272 62.895,13.144 63.367,11.504 C63.404,11.373 63.333,11.27 63.203,11.27 L62.536,11.27 C62.403,11.27 62.327,11.344 62.294,11.475 C62.148,12.06 61.778,12.675 61.043,12.675 C60.623,12.675 60.385,12.408 60.385,11.951 C60.385,11.561 61.39,7.709 61.39,7.709 L62.906,7.736 L62.906,7.736 Z M16.099,4.13 C16.052,4.845 15.453,5.426 14.763,5.426 C14.076,5.426 13.554,4.845 13.605,4.129 C13.656,3.414 14.251,2.833 14.94,2.833 C15.629,2.833 16.15,3.409 16.099,4.125 L16.099,4.13 Z M6.45,0 C2.246,0 0.01,2.825 0.01,5.902 C0,7.342 0.764,9.122 1.979,9.69 C2.164,9.775 2.262,9.737 2.304,9.559 C2.335,9.423 2.501,8.762 2.575,8.453 C2.606,8.355 2.595,8.269 2.513,8.172 C2.113,7.686 1.795,6.788 1.795,5.949 C1.795,3.8 3.426,1.72 6.194,1.72 C8.594,1.72 10.265,3.35 10.265,5.685 C10.265,8.322 8.942,10.148 7.209,10.148 C6.256,10.148 5.538,9.359 5.764,8.387 C6.041,7.228 6.574,5.977 6.574,5.136 C6.574,4.388 6.174,3.762 5.343,3.762 C4.369,3.762 3.58,4.767 3.58,6.131 C3.58,6.992 3.877,7.577 3.877,7.577 L2.707,12.428 C2.407,13.72 2.748,15.811 2.777,15.993 C2.792,16.09 2.9,16.124 2.961,16.041 C3.058,15.915 4.223,14.169 4.551,12.906 L5.156,10.588 C5.477,11.193 6.404,11.706 7.391,11.706 C10.331,11.706 12.45,9.003 12.45,5.644 C12.45,2.424 9.822,0.014 6.441,0.014 L6.45,0 Z" fill="#bd081c"></path></g></svg>) 50% 50% no-repeat;\n  background-size: 60px 15px;\n}\n .PIN_1492933324309_embed_grid .PIN_1492933324309_ft .PIN_1492933324309_button:hover { \n  box-shadow: inset 0 0 1px #000;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_noscroll .PIN_1492933324309_bd { \n  overflow: hidden;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_board .PIN_1492933324309_hd .PIN_1492933324309_pinner { \n  top: 10px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_board .PIN_1492933324309_hd .PIN_1492933324309_board { \n  white-space: nowrap;\n  overflow: hidden;\n  text-overflow: ellipsis;\n  width: 75%;\n  position: absolute;\n  bottom: 10px;\n  left: 56px;\n  color: #8e8e8e;\n  font-size: 12px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c2 { \n  max-width: 494px;\n  min-width: 140px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c2 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 50%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c3 { \n  max-width: 731px;\n  min-width: 200px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c3 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 33.33%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c4 { \n  max-width: 968px;\n  min-width: 260px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c4 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 25%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c5 { \n  max-width: 1205px;\n  min-width: 320px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c5 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 20%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c6 { \n  max-width: 1442px;\n  min-width: 380px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c6 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 16.66%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c7 { \n  max-width: 1679px;\n  min-width: 440px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c7 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 14.28%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c8 { \n  max-width: 1916px;\n  min-width: 500px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c8 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 12.5%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c9 { \n  max-width: 2153px;\n  min-width: 560px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c9 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 11.11%;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c10 { \n  max-width: 2390px;\n  min-width: 620px;\n}\n .PIN_1492933324309_embed_grid.PIN_1492933324309_c10 .PIN_1492933324309_bd .PIN_1492933324309_ct .PIN_1492933324309_col { \n  width: 10%;\n}\n .PIN_1492933324309_embed_pin { \n  width: 100%;\n  min-width: 160px;\n  max-width: 236px;\n  display: inline-block;\n  box-sizing: border-box;\n  box-shadow: inset 0 0 1px #000;\n  border-radius: 5px;\n  overflow: hidden;\n  font: 12px \"Helvetica Neue\", Helvetica, arial, sans-serif;\n  color: #363636;\n  background: #fff;\n  cursor: pointer;\n  -webkit-font-smoothing: antialiased;\n}\n .PIN_1492933324309_embed_pin * { \n  display: block;\n  position: relative;\n  font: inherit;\n  cursor: inherit;\n  box-sizing: inherit;\n  margin: 0;\n  padding: 0;\n  text-align: left;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd { \n  border-bottom: 1px solid rgba(0, 0, 0, 0.09);\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd { \n  border-bottom: 1px solid rgba(0, 0, 0, 0.09);\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container { \n  width: 100%;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_img,  .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_iframe,  .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_video { \n  width: 100%;\n  height: 100%;\n  position: absolute;\n  left: 0;\n  background: transparent url() 0 0 no-repeat;\n  background-size: cover;\n  border: none;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_native { \n  height: 64px;\n  width: 64px;\n  background: transparent url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iNjNweCIgd2lkdGg9IjYzcHgiIHZpZXdCb3g9IjAgMCA2NCA2NCI+PGc+PHBhdGggZD0iTSAzMiAzMiBtIC0zMiwgMCBhIDMxLCAzMSAwIDEsIDAgNjMsIDAgYSAzMSwgMzEgMCAxLDAgLTYzLCAwIHoiIGZpbGw9IiMwMDAiPjwvcGF0aD48cGF0aCBkPSJNIDI1IDE5IEwgNDggMzIgIEwgMjUgNDUgWiIgZmlsbD0iI2ZmZiI+PC9wYXRoPjwvZz48L3N2Zz4=) 0 0 no-repeat;\n  position: absolute;\n  top: 50%;\n  left: 50%;\n  margin-top: -32px;\n  margin-left: -32px;\n  opacity: .75;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_control { \n  width: 50px;\n  height: 24px;\n  position: absolute;\n  bottom: 12px;\n  left: 12px;\n  background: rgba(0, 0, 0, .4);\n  color: #fff;\n  box-shadow: 0 0 2px rgba(0, 0, 0, .2);\n  border: 2px solid rgba(255, 255, 255, .68);\n  border-radius: 13px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_control.PIN_1492933324309_paused::after,  .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_control.PIN_1492933324309_playing::after { \n  position: absolute;\n  top: 0;\n  left: 0;\n  width: 100%;\n  height: 100%;\n  font-size: 10px;\n  line-height: 19px;\n  white-space: pre;\n  font-weight: bold;\n  font-style: normal;\n  text-align: center;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_control.PIN_1492933324309_paused::after { \n  content: \"▶ GIF\";\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_control.PIN_1492933324309_playing::after { \n  content: \"❙ ❙ GIF\";\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_repin { \n  position: absolute;\n  top: 10px;\n  left: 10px;\n  height: 28px;\n  width: auto;\n  color: #fff;\n  background: #bd081c url(data:image/svg+xml;base64,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) 5px 50% no-repeat;\n  background-size: 18px 18px;\n  text-indent: 28px;\n  font: 14px/28px \"Helvetica Neue\", Helvetica, Arial, \"sans-serif\";\n  font-weight: bold;\n  border-radius: 4px;\n  padding: 0 6px 0 0;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_repin:hover { \n  background-color: #aa0719;\n  box-shadow: none;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source { \n  height: 38px;\n  border-bottom: 1px solid rgba(0, 0, 0, 0.09);\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_img { \n  position: absolute;\n  top: 50%;\n  margin-top: -8px;\n  left: 10px;\n  height: 16px;\n  width: 16px;\n  background: transparent url() 0 0 no-repeat;\n  background-size: 16px 16px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_domain { \n  line-height: 38px;\n  max-width: 75%;\n  white-space: nowrap;\n  overflow: hidden;\n  text-overflow: ellipsis;\n  font-weight: bold;\n  color: #b9b9b9;\n  position: absolute;\n  top: 0px;\n  left: 35px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source.PIN_1492933324309_nofav .PIN_1492933324309_img { \n  display: none;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source.PIN_1492933324309_nofav .PIN_1492933324309_domain { \n  max-width: 85%;\n  left: 10px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_menu { \n  height: inherit;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_menu .PIN_1492933324309_toggle { \n  position: absolute;\n  top: 0;\n  right: 5px;\n  height: inherit;\n  width: 30px;\n  border-bottom: 1px solid rgba(0, 0, 0, 0.09);\n  background: #fff url(data:image/svg+xml;base64,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) 50% 50% no-repeat;\n  background-size: fill;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_menu .PIN_1492933324309_dropdown { \n  display: none;\n  border-radius: 5px;\n  box-shadow: 0 1px 3px rgba(0, 0, 0, .33);\n  font-weight: bold;\n  font-size: 12px;\n  background: #fff;\n  text-align: left;\n  padding: 10px;\n  position: absolute;\n  max-width: 195px;\n  right: 10px;\n  top: 39px;\n  z-index: 1;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_menu .PIN_1492933324309_dropdown::after { \n  content: \"\";\n  position: absolute;\n  top: -6px;\n  right: 1px;\n  border-bottom: 8px solid #fff;\n  border-right: 8px solid transparent;\n  border-left: 8px solid transparent;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_menu .PIN_1492933324309_dropdown::before { \n  content: \"\";\n  position: absolute;\n  top: -7px;\n  right: 2px;\n  border-bottom: 7px solid #e2e2e2;\n  border-right: 7px solid transparent;\n  border-left: 7px solid transparent;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_description { \n  font-size: 14px;\n  line-height: 17px;\n  margin: 8px 12px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_attribution { \n  height: 22px;\n  margin-top: 5px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_attribution .PIN_1492933324309_img { \n  position: absolute;\n  top: 50%;\n  margin-top: -8px;\n  left: 10px;\n  height: 16px;\n  width: 16px;\n  background: transparent url() 0 0 no-repeat;\n  background-size: 16px 16px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_attribution .PIN_1492933324309_by { \n  line-height: 22px;\n  max-width: 75%;\n  white-space: nowrap;\n  overflow: hidden;\n  text-overflow: ellipsis;\n  font-size: 11px;\n  font-weight: bold;\n  color: #b9b9b9;\n  position: absolute;\n  top: 0px;\n  left: 35px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_stats { \n  height: 24px;\n  line-height: 24px;\n  margin: 0 0 0 10px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_stats .PIN_1492933324309_repins,  .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_stats .PIN_1492933324309_likes { \n  padding-left: 17px;\n  padding-right: 10px;\n  color: #a8a8a8;\n  font-size: 11px;\n  font-weight: bold;\n  display: inline-block;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_stats .PIN_1492933324309_repins { \n  background: transparent url(data:image/svg+xml;base64,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) 0 50% no-repeat;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_bd .PIN_1492933324309_stats .PIN_1492933324309_likes { \n  background: transparent url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMTNweCIgd2lkdGg9IjE1cHgiIHZpZXdCb3g9IjAgMCAxNSAxMyI+PGc+PHBhdGggZD0iTTcuMzY5LDEyLjQzNyBMMS40NDEsNi40MSBDMC4yMTcsNS4xNjUgMCwzLjE1NiAxLjA2OCwxLjc3IEMyLjM0OCwwLjEwOCA0LjcyLDAgNi4xNDIsMS40NDYgTDcuMzY5LDIuNjk0IEw4LjUwNiwxLjUzOSBDOS43MywwLjI5MyAxMS43MDYsMC4wNzMgMTMuMDcsMS4xNTkgQzE0LjcwNSwyLjQ2MSAxNC44MTEsNC44NzIgMTMuMzg4LDYuMzE4IEw3LjM2OSwxMi40MzcgWiIgZmlsbD0iI2I1YjViNSI+PC9wYXRoPjwvZz48L3N2Zz4=) 0 51% no-repeat;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_ft { \n  height: 50px;\n  margin-right: 10px;\n  overflow: hidden;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_ft:after { \n  content: '-------------------------------------------------------------------------------------';\n  display: block;\n  height: 1px;\n  line-height: 1px;\n  color: #fff;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_ft .PIN_1492933324309_img { \n  position: absolute;\n  left: 10px;\n  top: 10px;\n  height: 30px;\n  width: 30px;\n  border-radius: 30px;\n  background: transparent url() 0 0 no-repeat;\n  background-size: 30px 30px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_ft .PIN_1492933324309_pinner,  .PIN_1492933324309_embed_pin .PIN_1492933324309_ft  .PIN_1492933324309_board { \n  position: absolute;\n  left: 50px;\n  white-space: nowrap;\n  overflow: hidden;\n  text-overflow: ellipsis;\n  width: 75%;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_ft .PIN_1492933324309_pinner { \n  font-weight: bold;\n  top: 10px;\n}\n .PIN_1492933324309_embed_pin .PIN_1492933324309_ft .PIN_1492933324309_board { \n  bottom: 10px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_ja .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_repin { \n  background-image: url(data:image/svg+xml;base64,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);\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_ja .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_repin.PIN_1492933324309_save { \n  background: #bd081c url(data:image/svg+xml;base64,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) 5px 50% no-repeat;\n  background-size: 16px 16px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_medium { \n  min-width: 237px;\n  max-width: 345px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large { \n  min-width: 345px;\n  max-width: 600px;\n  padding: 30px 34px 10px;\n  font-size: 14px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd { \n  border-bottom: none;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_hd { \n  padding-top: 50px;\n  border-bottom: none;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_img,  .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_container .PIN_1492933324309_video { \n  border-radius: 8px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_hd .PIN_1492933324309_repin { \n  top: 0px;\n  left: 0px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_source { \n  height: 50px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_source .PIN_1492933324309_domain { \n  line-height: 50px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_stats { \n  position: absolute;\n  top: 0;\n  right: 0;\n  text-align: right;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_description { \n  font-size: 16px;\n  line-height: 20px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_menu { \n  height: inherit;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_bd .PIN_1492933324309_menu .PIN_1492933324309_dropdown { \n  top: 50px;\n  font-size: 14px;\n  padding: 10px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_ft { \n  height: 60px;\n  font-size: 16px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_ft .PIN_1492933324309_board,  .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_ft .PIN_1492933324309_pinner { \n  left: 60px;\n}\n .PIN_1492933324309_embed_pin.PIN_1492933324309_large .PIN_1492933324309_ft .PIN_1492933324309_img { \n  height: 40px;\n  width: 40px;\n  background-size: 40px 40px;\n  border-radius: 20px;\n}\n .PIN_1492933324309_button_follow { \n  display: inline-block;\n  color: #363636;\n  box-sizing: border-box;\n  box-shadow: inset 0 0 1px #888;\n  border-radius: 3px;\n  font: 11px \"Helvetica Neue\", Helvetica, arial, sans-serif;\n  font-weight: bold;\n  cursor: pointer;\n  -webkit-font-smoothing: antialiased;\n  height: 20px;\n  line-height: 20px;\n  padding: 0 4px 0 20px;\n  background-color: #efefef;\n  position: relative;\n  white-space: nowrap;\n  vertical-align: baseline;\n}\n .PIN_1492933324309_button_follow:hover { \n  box-shadow: inset 0 0 1px #000;\n}\n .PIN_1492933324309_button_follow::after { \n  content: \"\";\n  position: absolute;\n  height: 14px;\n  width: 14px;\n  top: 3px;\n  left: 3px;\n  background: transparent url(data:image/svg+xml;base64,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) 0 0 no-repeat;\n  background-size: 14px 14px;\n}\n .PIN_1492933324309_button_follow.PIN_1492933324309_tall { \n  height: 26px;\n  line-height: 26px;\n  font-size: 13px;\n  padding: 0 6px 0 25px;\n  border-radius: 3px;\n}\n .PIN_1492933324309_button_follow.PIN_1492933324309_tall::after { \n  height: 18px;\n  width: 18px;\n  top: 4px;\n  left: 4px;\n  background-size: 18px 18px;\n}\n .PIN_1492933324309_button_pin { \n  cursor: pointer;\n  display: inline-block;\n  box-sizing: border-box;\n  box-shadow: inset 0 0 1px #888;\n  border-radius: 3px;\n  height: 20px;\n  width: 40px;\n  -webkit-font-smoothing: antialiased;\n  background: #efefef url(data:image/svg+xml;base64,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) 50% 50% no-repeat;\n  background-size: 75%;\n  position: relative;\n  font: 12px \"Helvetica Neue\", Helvetica, arial, sans-serif;\n  color: #555;\n  text-align: center;\n  vertical-align: baseline;\n}\n .PIN_1492933324309_button_pin:hover { \n  box-shadow: inset 0 0 1px #000;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_above .PIN_1492933324309_count { \n  position: absolute;\n  top: -28px;\n  left: 0;\n  height: 28px;\n  width: inherit;\n  line-height: 24px;\n  background: transparent url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iNzZweCIgd2lkdGg9IjExNHB4IiB2aWV3Qm94PSIwIDAgMTE0IDc2Ij48Zz48cGF0aCBkPSJNOSAxQzQuNiAxIDEgNC42IDEgOXY0M2MwIDQuMyAzLjYgOCA4IDhoMjZsMTggMTVoNy41bDE2LTE1SDEwNWM0LjQgMCA4LTMuNyA4LThWOWMwLTQuNC0zLjYtOC04LThIOXoiIGZpbGw9IiNmZmYiIHN0cm9rZT0iI2I1YjViNSIgc3Ryb2tlLXdpZHRoPSIyIj48L3BhdGg+PC9nPjwvc3ZnPg==) 0 0 no-repeat;\n  background-size: 40px 28px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_above.PIN_1492933324309_padded { \n  margin-top: 28px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_beside .PIN_1492933324309_count { \n  position: absolute;\n  right: -45px;\n  text-align: center;\n  text-indent: 5px;\n  height: inherit;\n  width: 45px;\n  font-size: 11px;\n  line-height: 20px;\n  background: transparent url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iNTZweCIgd2lkdGg9IjEyNnB4IiB2aWV3Qm94PSIyIDAgMTMwIDYwIj48Zz48cGF0aCBkPSJNMTE5LjYgMmM0LjUgMCA4IDMuNiA4IDh2NDBjMCA0LjQtMy41IDgtOCA4SDIzLjNMMS42IDMyLjR2LTQuNkwyMy4zIDJoOTYuM3oiIGZpbGw9IiNmZmYiIHN0cm9rZT0iI2I1YjViNSIgc3Ryb2tlLXdpZHRoPSIyIj48L3BhdGg+PC9nPjwvc3ZnPg==);\n  background-size: cover;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_beside.PIN_1492933324309_padded { \n  margin-right: 45px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_ja { \n  background-image: url(data:image/svg+xml;base64,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);\n  background-size: 72%;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_red { \n  background-color: #bd081c;\n  background-image: url(data:image/svg+xml;base64,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);\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_red.PIN_1492933324309_ja { \n  background-image: url(data:image/svg+xml;base64,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);\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_white { \n  background-color: #fff;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save { \n  border-radius: 2px;\n  text-indent: 20px;\n  width: auto;\n  padding: 0 4px 0 0;\n  text-align: center;\n  font: 11px/20px \"Helvetica Neue\", Helvetica, sans-serif;\n  font-weight: bold;\n  color: #fff;\n  background: #bd081c url(data:image/svg+xml;base64,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) 3px 50% no-repeat;\n  background-size: 14px 14px;\n  -webkit-font-smoothing: antialiased;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save:hover { \n  background-color: #aa0719;\n  box-shadow: none;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save .PIN_1492933324309_count { \n  text-indent: 0;\n  position: absolute;\n  color: #555;\n  background: #efefef;\n  border-radius: 2px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save .PIN_1492933324309_count::before { \n  content: \"\";\n  position: absolute;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save.PIN_1492933324309_beside .PIN_1492933324309_count { \n  right: -46px;\n  height: 20px;\n  width: 40px;\n  font-size: 10px;\n  line-height: 20px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save.PIN_1492933324309_beside .PIN_1492933324309_count::before { \n  top: 3px;\n  left: -4px;\n  border-right: 7px solid #efefef;\n  border-top: 7px solid transparent;\n  border-bottom: 7px solid transparent;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save.PIN_1492933324309_above .PIN_1492933324309_count { \n  top: -36px;\n  width: 100%;\n  height: 30px;\n  font-size: 10px;\n  line-height: 30px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save.PIN_1492933324309_above .PIN_1492933324309_count::before { \n  bottom: -4px;\n  left: 4px;\n  border-top: 7px solid #efefef;\n  border-right: 7px solid transparent;\n  border-left: 7px solid transparent;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_save.PIN_1492933324309_above.PIN_1492933324309_padded { \n  margin-top: 28px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall { \n  height: 28px;\n  width: 56px;\n  border-radius: 3px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_above .PIN_1492933324309_count { \n  position: absolute;\n  height: 37px;\n  width: inherit;\n  top: -37px;\n  left: 0;\n  line-height: 30px;\n  font-size: 14px;\n  background: transparent url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iNzZweCIgd2lkdGg9IjExNHB4IiB2aWV3Qm94PSIwIDAgMTE0IDc2Ij48Zz48cGF0aCBkPSJNOSAxQzQuNiAxIDEgNC42IDEgOXY0M2MwIDQuMyAzLjYgOCA4IDhoMjZsMTggMTVoNy41bDE2LTE1SDEwNWM0LjQgMCA4LTMuNyA4LThWOWMwLTQuNC0zLjYtOC04LThIOXoiIGZpbGw9IiNmZmYiIHN0cm9rZT0iI2I1YjViNSIgc3Ryb2tlLXdpZHRoPSIyIj48L3BhdGg+PC9nPjwvc3ZnPg==);\n  background-size: cover;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_above.PIN_1492933324309_padded { \n  margin-top: 37px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_beside .PIN_1492933324309_count { \n  text-indent: 5px;\n  position: absolute;\n  right: -63px;\n  height: inherit;\n  width: 63px;\n  font-size: 14px;\n  line-height: 28px;\n  background: transparent url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iNTZweCIgd2lkdGg9IjEyNnB4IiB2aWV3Qm94PSIyIDAgMTMwIDYwIj48Zz48cGF0aCBkPSJNMTE5LjYgMmM0LjUgMCA4IDMuNiA4IDh2NDBjMCA0LjQtMy41IDgtOCA4SDIzLjNMMS42IDMyLjR2LTQuNkwyMy4zIDJoOTYuM3oiIGZpbGw9IiNmZmYiIHN0cm9rZT0iI2I1YjViNSIgc3Ryb2tlLXdpZHRoPSIyIj48L3BhdGg+PC9nPjwvc3ZnPg==);\n  background-size: cover;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_beside.PIN_1492933324309_padded { \n  margin-right: 63px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save { \n  border-radius: 4px;\n  width: auto;\n  background-position-x: 6px;\n  background-size: 18px 18px;\n  text-indent: 29px;\n  font: 14px/28px \"Helvetica Neue\", Helvetica, Arial, \"sans-serif\";\n  font-weight: bold;\n  padding: 0 6px 0 0;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save .PIN_1492933324309_count { \n  position: absolute;\n  color: #555;\n  font-size: 12px;\n  text-indent: 0;\n  background: #efefef;\n  border-radius: 4px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save .PIN_1492933324309_count::before { \n  content: \"\";\n  position: absolute;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save.PIN_1492933324309_above .PIN_1492933324309_count { \n  font-size: 14px;\n  top: -50px;\n  width: 100%;\n  height: 44px;\n  line-height: 44px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save.PIN_1492933324309_above .PIN_1492933324309_count::before { \n  bottom: -4px;\n  left: 7px;\n  border-top: 7px solid #efefef;\n  border-right: 7px solid transparent;\n  border-left: 7px solid transparent;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save.PIN_1492933324309_beside .PIN_1492933324309_count { \n  font-size: 14px;\n  right: -63px;\n  width: 56px;\n  height: 28px;\n  line-height: 28px;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_tall.PIN_1492933324309_save.PIN_1492933324309_beside .PIN_1492933324309_count::before { \n  top: 7px;\n  left: -4px;\n  border-right: 7px solid #efefef;\n  border-top: 7px solid transparent;\n  border-bottom: 7px solid transparent;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_round { \n  height: 16px;\n  width: 16px;\n  background: transparent url(data:image/svg+xml;base64,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) 0 0 no-repeat;\n  background-size: 16px 16px;\n  box-shadow: none;\n}\n .PIN_1492933324309_button_pin.PIN_1492933324309_round.PIN_1492933324309_tall { \n  height: 32px;\n  width: 32px;\n  background-size: 32px 32px;\n}\n</style></head>\n\n<body class=\"home blog custom-background two-column right-sidebar\">\n<div id=\"page\" class=\"hfeed\">\n\t<header id=\"branding\" role=\"banner\">\n\t\t\t<hgroup>\n\t\t\t\t<h1 id=\"site-title\"><span><a href=\"http://www.covance.com\" title=\"www.covance.com\" rel=\"www.covance.com\">Covance Blog</a></span></h1>\n\t\t\t\t<h2 id=\"site-description\">Sharing Innovation in Drug Development</h2>\n \n\n\t\t\t</hgroup>\n\n\t\t\t\t\t\t<a href=\"http://www.covance.com\">\n\t\t\t\t\t\t\t\t\t<img src=\"http://blog.covance.com/wp-content/uploads/2015/10/cropped-Covance-Labs-Scientific-Blog.jpg\" width=\"1000\" height=\"288\" alt=\"\">\n\t\t\t\t\t\t\t</a>\n\t\t\t\n\t\t\t\t\t\t\t<div class=\"only-search with-image\">\n\t\t\t\t<!---?php get_search_form(); ?--->\n\t\t\t\t</div>\n\t\t\t\n\t\t\t<nav id=\"access\" role=\"navigation\">\n\t\t\t\t<h3 class=\"assistive-text\">Main menu</h3>\n\t\t\t\t\t\t\t\t<div class=\"skip-link\"><a class=\"assistive-text\" href=\"#content\" title=\"Skip to primary content\">Skip to primary content</a></div>\n\t\t\t\t<div class=\"skip-link\"><a class=\"assistive-text\" href=\"#secondary\" title=\"Skip to secondary content\">Skip to secondary content</a></div>\n\t\t\t\t\t\t\t\t<nav id=\"megaMenu\" class=\"megaMenuContainer megaFullWidth megaMenuHorizontal megaMenuOnHover wpmega-withjs wpmega-noconflict megaMenu-withjs\"><ul id=\"megaUber\" class=\"megaMenu\"><li id=\"menu-item-1803\" class=\"menu-item menu-item-type-custom menu-item-object-custom current-menu-ancestor current-menu-parent menu-item-has-children ss-nav-menu-item-0 ss-nav-menu-item-depth-0 ss-nav-menu-reg mega-with-sub\"><a><span class=\"wpmega-link-title\">MENU</span></a>\n<ul class=\"sub-menu sub-menu-1\" style=\"display: none;\">\n\t<li id=\"menu-item-101\" class=\"menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home ss-nav-menu-item-depth-1\"><a title=\"Home\" href=\"http://blog.covance.com\"><span class=\"wpmega-link-title\">Home</span></a></li>\n\t<li id=\"menu-item-1804\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children ss-nav-menu-item-depth-1 megaReg-with-sub\"><a title=\"Drug Development\" href=\"http://blog.covance.com/drug-development/\"><span class=\"wpmega-link-title\">Drug Development</span></a>\n\t<ul class=\"sub-menu sub-menu-2\" style=\"display: none;\">\n\t\t<li id=\"menu-item-1805\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Lead Optimization\" href=\"http://blog.covance.com/drug-development/lead-optimization-drug-development/\"><span class=\"wpmega-link-title\">Lead Optimization</span></a></li>\n\t\t<li id=\"menu-item-1806\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Analytical Services\" href=\"http://blog.covance.com/drug-development/analytical-services/\"><span class=\"wpmega-link-title\">Analytical Services</span></a></li>\n\t\t<li id=\"menu-item-1807\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Safety Assessment\" href=\"http://blog.covance.com/drug-development/safety-assessment/\"><span class=\"wpmega-link-title\">Safety Assessment</span></a></li>\n\t\t<li id=\"menu-item-1808\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Consulting\" href=\"http://blog.covance.com/drug-development/consulting/\"><span class=\"wpmega-link-title\">Consulting</span></a></li>\n\t\t<li id=\"menu-item-1809\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Clinical Development\" href=\"http://blog.covance.com/drug-development/clinical-development/\"><span class=\"wpmega-link-title\">Clinical Development</span></a></li>\n\t\t<li id=\"menu-item-1810\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Clinical Testing\" href=\"http://blog.covance.com/drug-development/central-laboratory-services/\"><span class=\"wpmega-link-title\">Clinical Testing</span></a></li>\n\t\t<li id=\"menu-item-1811\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Health Economics &amp; Market Access\" href=\"http://blog.covance.com/drug-development/health-economics-market-access/\"><span class=\"wpmega-link-title\">Health Economics &amp; Market Access</span></a></li>\n\t\t<li id=\"menu-item-1812\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-2\"><a title=\"Manufacturing Support\" href=\"http://blog.covance.com/drug-development/manufacturing-support/\"><span class=\"wpmega-link-title\">Manufacturing Support</span></a></li>\n\t</ul>\n</li>\n\t<li id=\"menu-item-1813\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-1\"><a title=\"Food Solutions\" href=\"http://blog.covance.com/foodsolutions/\"><span class=\"wpmega-link-title\">Food Solutions</span></a></li>\n\t<li id=\"menu-item-1814\" class=\"menu-item menu-item-type-taxonomy menu-item-object-category ss-nav-menu-item-depth-1\"><a title=\"Healthcare\" href=\"http://blog.covance.com/healthcare/\"><span class=\"wpmega-link-title\">Healthcare</span></a></li>\n\t<li id=\"menu-item-285\" class=\"menu-item menu-item-type-custom menu-item-object-custom ss-nav-menu-item-depth-1\"><a title=\"Contact\" href=\"http://Response.covance.com/blog?elqCampaignId=101\"><span class=\"wpmega-link-title\">Contact Us</span></a></li>\n\t<li id=\"menu-item-496\" class=\"menu-item menu-item-type-custom menu-item-object-custom ss-nav-menu-item-depth-1\"><a title=\"Careers\" href=\"http://careers.covance.com\"><span class=\"wpmega-link-title\">Careers</span></a></li>\n\t<li id=\"menu-item-39\" class=\"menu-item menu-item-type-custom menu-item-object-custom ss-nav-menu-item-depth-1\"><a title=\"Covance.com\" href=\"http://www.covance.com\"><span class=\"wpmega-link-title\">Covance.com</span></a></li>\n</ul>\n</li>\n</ul></nav>\t\t\t</nav><!-- #access -->\n\n<script type=\"text/javascript\">\n    var _elqQ = _elqQ || [];\n    _elqQ.push(['elqSetSiteId', '409256115']);\n    _elqQ.push(['elqTrackPageView']);\n    \n    (function () {\n        function async_load() {\n            var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true;\n            s.src = '//img03.en25.com/i/elqCfg.min.js';\n            var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);\n        }\n        if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);\n        else if (window.attachEvent) window.attachEvent('onload', async_load); \n    })();\n</script>\t\n\n</header><!-- #branding -->\n\n\n\t<div id=\"main\">\n\t\t<div id=\"primary\">\n\t\t\t<div id=\"content\" role=\"main\">\n\n\t\t\t\n\t\t\t\t\t\t<nav id=\"nav-above\">\n\t\t\t<h3 class=\"assistive-text\">Post navigation</h3>\n\t\t\t<div class=\"nav-previous\"><a href=\"http://blog.covance.com/page/2/\"><span class=\"meta-nav\">←</span> Older posts</a></div>\n\t\t\t<div class=\"nav-next\"></div>\n\t\t</nav><!-- #nav-above -->\n\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3089\" class=\"post-3089 post type-post status-publish format-standard hentry category-clinical-development category-drug-development tag-central-laboratory-services-2 tag-chikungunya tag-covance tag-dengue tag-immunotherapeutic-development tag-measles tag-mmrv-testing tag-mumps tag-rubella tag-vaccine-development tag-vaccines tag-varicella tag-zika tag-zika-virus\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/04/measles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation/\" title=\"Permalink to Stepping Up the Game: Measles, Mumps, Rubella and Varicella (MMRV) Concomitant Testing Support for Vaccine Evaluation\" rel=\"bookmark\">Stepping Up the Game: Measles, Mumps, Rubella and Varicella (MMRV) Concomitant Testing Support for Vaccine Evaluation</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/rpajonphd/\" title=\"View all posts by Rolando Pajon, PhD\" rel=\"author\">Rolando Pajon, PhD</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/04/measles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation/\" title=\"9:35 am\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-04-12T09:35:01+00:00\" pubdate=\"\">Wednesday, April 12, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>The introduction of vaccines against Measles, Mumps, Rubella (MMR), and Varicella (the “V” in MMRV vaccines) led to a drop in the incidence of these diseases by 89% (Varicella) and 99% (MMR). These effective vaccines are a core component in most pediatric immunization programs across the world. Hence, every time a new <a href=\"http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april.jpg\" rel=\"lightbox[3089]\" title=\"Stepping Up the Game: Measles, Mumps, Rubella and Varicella (MMRV) Concomitant Testing Support for Vaccine Evaluation\" class=\"cboxElement\"><img data-attachment-id=\"3090\" data-permalink=\"http://blog.covance.com/2017/04/measles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation/measles-virus-illustration/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april.jpg\" data-orig-size=\"6000,4000\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;Measles virus. 3D illustration showing structure of measles virus with surface glycoprotein spikes heamagglutinin-neuraminidase and fusion protein&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;Measles virus illustration&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Measles virus illustration\" data-image-description=\"\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-1024x683.jpg\" class=\"alignright size-medium wp-image-3090\" src=\"http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-1024x683.jpg 1024w, http://blog.covance.com/wp-content/uploads/2017/04/vaccine-graphic-covance-april-450x300.jpg 450w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>pediatric vaccine is added to the existing immunization schedule, clinical evidence must be provided that the newcomer does not adversely influence the immunogenic response to the MMRV-licensed vaccines. These required non-inferiority studies when vaccines are co-administered (known as concomitant vaccine testing) come with their own challenges.</p>\n<p> <a href=\"http://blog.covance.com/2017/04/measles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation/#more-3089\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F04%2Fmeasles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation%2F&amp;title=Stepping+Up+the+Game%3A+Measles%2C+Mumps%2C+Rubella+and+Varicella+%28MMRV%29+Concomitant+Testing+Support+for+Vaccine+Evaluation&amp;desc=The+introduction+of+vaccines+against+Measles%2C+Mumps%2C+Rubella+%28MMR%29%2C+and+Varicella+%28the+%E2%80%9CV%E2%80%9D+in+MMRV+vaccines%29+led+to+a+drop+in+the+incidence+of+these+diseases+by+89%25+%28Varicella%29+and+99%25+%28MMR%29.+These+effective+vaccines+are+a+core+component+in+most+pediatric+immunization+programs+across+the+world.&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/clinical-development/\" rel=\"category tag\">Clinical Development</a>, <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/central-laboratory-services-2/\" rel=\"tag\">central laboratory services</a>, <a href=\"http://blog.covance.com/tag/chikungunya/\" rel=\"tag\">Chikungunya</a>, <a href=\"http://blog.covance.com/tag/covance/\" rel=\"tag\">Covance</a>, <a href=\"http://blog.covance.com/tag/dengue/\" rel=\"tag\">Dengue</a>, <a href=\"http://blog.covance.com/tag/immunotherapeutic-development/\" rel=\"tag\">immunotherapeutic development</a>, <a href=\"http://blog.covance.com/tag/measles/\" rel=\"tag\">Measles</a>, <a href=\"http://blog.covance.com/tag/mmrv-testing/\" rel=\"tag\">MMRV Testing</a>, <a href=\"http://blog.covance.com/tag/mumps/\" rel=\"tag\">Mumps</a>, <a href=\"http://blog.covance.com/tag/rubella/\" rel=\"tag\">Rubella</a>, <a href=\"http://blog.covance.com/tag/vaccine-development/\" rel=\"tag\">Vaccine Development</a>, <a href=\"http://blog.covance.com/tag/vaccines/\" rel=\"tag\">vaccines</a>, <a href=\"http://blog.covance.com/tag/varicella/\" rel=\"tag\">Varicella</a>, <a href=\"http://blog.covance.com/tag/zika/\" rel=\"tag\">Zika</a>, <a href=\"http://blog.covance.com/tag/zika-virus/\" rel=\"tag\">Zika Virus</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3089 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3076\" class=\"post-3076 post type-post status-publish format-standard hentry category-consulting category-drug-development category-uncategorized tag-biomarkers tag-clinical-trials tag-covance tag-diabetes tag-heart-failure tag-immuno-oncology tag-nash tag-oncology tag-orphan-drugs tag-rare-diseases tag-webinar\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/04/hot-topics-discussed-in-covance-spring-webinars/\" title=\"Permalink to Hot Topics Discussed in Covance Spring Webinars\" rel=\"bookmark\">Hot Topics Discussed in Covance Spring Webinars</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/covance/\" title=\"View all posts by Covance Inc.\" rel=\"author\">Covance Inc.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/04/hot-topics-discussed-in-covance-spring-webinars/\" title=\"10:01 am\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-04-11T10:01:08+00:00\" pubdate=\"\">Tuesday, April 11, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>Unlock opportunities for your clinical research programs and deliver results that <a href=\"http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers.jpg\" rel=\"lightbox[3076]\" title=\"Hot Topics Discussed in Covance Spring Webinars\" class=\"cboxElement\"><img data-attachment-id=\"3081\" data-permalink=\"http://blog.covance.com/2017/04/hot-topics-discussed-in-covance-spring-webinars/covance-spring-webinars-video-nash-diabetic-heart-biomarkers/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers.jpg\" data-orig-size=\"1500,1000\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Covance Spring Webinars Video Nash Diabetic Heart Biomarkers\" data-image-description=\"<p>Covance Spring Webinars Video Nash Diabetic Heart Biomarkers</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-1024x683.jpg\" class=\"alignright wp-image-3081 size-medium\" src=\"http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-300x200.jpg\" alt=\"Covance Spring Webinars Video Nash Diabetic Heart Biomarkers\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-1024x683.jpg 1024w, http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-450x300.jpg 450w, http://blog.covance.com/wp-content/uploads/2017/04/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers.jpg 1500w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>matter.<br>\nWe’re excited to be on the cutting edge of drug development solutions. Take a look at past and future webinar topics and leverage our experience.</p>\n<p><strong>Kidney Biomarkers in Drug Development</strong></p>\n<p>Experts discuss emerging translational biomarkers and insights into evaluation of nonclinical urine biomarker data.&nbsp; We’ll also discuss translational biomarkers in clinical trials for recent renal-related diseases/mechanisms. <a href=\"http://blog.covance.com/2017/04/hot-topics-discussed-in-covance-spring-webinars/#more-3076\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F04%2Fhot-topics-discussed-in-covance-spring-webinars%2F&amp;title=Hot+Topics+Discussed+in+Covance+Spring+Webinars&amp;desc=Unlock+opportunities+for+your+clinical+research+programs+and+deliver+results+that+matter.+We%27re+excited+to+be+on+the+cutting+edge+of+drug+development+solutions.+Take+a+look+at+past+and+future+webinar+topics+and+leverage+our+experience.+Kidney+Biomarkers+in+Drug+Development+Experts+discuss+emerging&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/consulting/\" rel=\"category tag\">Consulting</a>, <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>, <a href=\"http://blog.covance.com/uncategorized/\" rel=\"category tag\">Uncategorized</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/biomarkers/\" rel=\"tag\">Biomarkers</a>, <a href=\"http://blog.covance.com/tag/clinical-trials/\" rel=\"tag\">clinical trials</a>, <a href=\"http://blog.covance.com/tag/covance/\" rel=\"tag\">Covance</a>, <a href=\"http://blog.covance.com/tag/diabetes/\" rel=\"tag\">Diabetes</a>, <a href=\"http://blog.covance.com/tag/heart-failure/\" rel=\"tag\">Heart Failure</a>, <a href=\"http://blog.covance.com/tag/immuno-oncology/\" rel=\"tag\">Immuno-Oncology</a>, <a href=\"http://blog.covance.com/tag/nash/\" rel=\"tag\">NASH</a>, <a href=\"http://blog.covance.com/tag/oncology/\" rel=\"tag\">Oncology</a>, <a href=\"http://blog.covance.com/tag/orphan-drugs/\" rel=\"tag\">Orphan Drugs</a>, <a href=\"http://blog.covance.com/tag/rare-diseases/\" rel=\"tag\">Rare Diseases</a>, <a href=\"http://blog.covance.com/tag/webinar/\" rel=\"tag\">webinar</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3076 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3068\" class=\"post-3068 post type-post status-publish format-standard hentry category-drug-development tag-awards tag-clinical-research tag-dimitris-agrafiotis tag-medical-review tag-xcellerate\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/03/clinical-research-excellence-awards-shortlist-xcellerate-medical-review/\" title=\"Permalink to Clinical &amp; Research Excellence Awards Shortlist Xcellerate Medical Review\" rel=\"bookmark\">Clinical &amp; Research Excellence Awards Shortlist Xcellerate Medical Review</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/covance/\" title=\"View all posts by Covance Inc.\" rel=\"author\">Covance Inc.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/03/clinical-research-excellence-awards-shortlist-xcellerate-medical-review/\" title=\"4:39 pm\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-03-27T16:39:15+00:00\" pubdate=\"\">Monday, March 27, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>Covance is excited to announce that Xcellerate<sup>®</sup> Medical Review has been named a finalist in the <a href=\"https://ibiawards.com/careawards/shortlist/\">Clinical &amp; Research Excellence (CARE) Awards</a>. As a finalist in the Best Sponsor-Focused Technological Development<strong>&nbsp;</strong>category, Xcellerate Medical Review is <a href=\"http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog.jpg\" rel=\"lightbox[3068]\" title=\"Clinical &amp; Research Excellence Awards Shortlist Xcellerate Medical Review\" class=\"cboxElement\"><img data-attachment-id=\"3070\" data-permalink=\"http://blog.covance.com/2017/03/clinical-research-excellence-awards-shortlist-xcellerate-medical-review/clinical-trial-data-xcellerate-informatics-covance-blog-2/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog.jpg\" data-orig-size=\"1500,1000\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Clinical Trial Data Xcellerate Informatics Covance Blog\" data-image-description=\"<p>Clinical &amp; Research Excellence Awards Shortlist Xcellerate Medical Review from Covance Labs</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-1024x683.jpg\" class=\"alignright size-medium wp-image-3070\" src=\"http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-300x200.jpg\" alt=\"Clinical &amp; Research Excellence Awards Shortlist Xcellerate Medical Review\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-1024x683.jpg 1024w, http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog-450x300.jpg 450w, http://blog.covance.com/wp-content/uploads/2017/03/Clinical-Trial-Data-Xcellerate-Informatics-Covance-Blog.jpg 1500w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>being recognized for its modern approach to improving the clinical trial process. The CARE Awards recognize excellence across the global clinical research enterprise.</p>\n<p>The Xcellerate Medical Review informatics product provides a critical function to study sponsors to safeguard subject safety, increase the robustness and quality of clinical trial execution, improve the reliability of investigational data and ensure adherence to ethical standards. Xcellerate Medical Review is a part of the larger award-winning Xcellerate Clinical Trial Optimization<sup>®</sup> suite, a comprehensive informatics solution that can meaningfully reduce the cost, time, complexity and risk of drug development. <a href=\"http://blog.covance.com/2017/03/clinical-research-excellence-awards-shortlist-xcellerate-medical-review/#more-3068\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F03%2Fclinical-research-excellence-awards-shortlist-xcellerate-medical-review%2F&amp;title=Clinical+%26amp%3B+Research+Excellence+Awards+Shortlist+Xcellerate+Medical+Review&amp;desc=Covance+is+excited+to+announce+that+Xcellerate%C2%AE+Medical+Review+has+been+named+a+finalist+in+the+Clinical+%26amp%3Bamp%3B+Research+Excellence+%28CARE%29+Awards.+As+a+finalist+in+the+Best+Sponsor-Focused+Technological+Development%C2%A0category%2C+Xcellerate+Medical+Review+is+being+recognized+for+its+modern+approach+to&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/awards/\" rel=\"tag\">Awards</a>, <a href=\"http://blog.covance.com/tag/clinical-research/\" rel=\"tag\">Clinical Research</a>, <a href=\"http://blog.covance.com/tag/dimitris-agrafiotis/\" rel=\"tag\">Dimitris Agrafiotis</a>, <a href=\"http://blog.covance.com/tag/medical-review/\" rel=\"tag\">Medical Review</a>, <a href=\"http://blog.covance.com/tag/xcellerate/\" rel=\"tag\">Xcellerate</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3068 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3020\" class=\"post-3020 post type-post status-publish format-standard hentry category-clinical-development category-drug-development tag-cgmp tag-clinical-research-unit tag-cru tag-drug-development tag-pharmacy\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/03/phase-i-cgmp-drug-manufacture-at-the-cru/\" title=\"Permalink to Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits\" rel=\"bookmark\">Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/marcus-stavchansky/\" title=\"View all posts by Marcus Stavchansky, PharmD\" rel=\"author\">Marcus Stavchansky, PharmD</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/03/phase-i-cgmp-drug-manufacture-at-the-cru/\" title=\"1:40 pm\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-03-17T13:40:41+00:00\" pubdate=\"\">Friday, March 17, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<h2><strong>Using a <a class=\"zem_slink\" title=\"Good manufacturing practice\" href=\"http://en.wikipedia.org/wiki/Good_manufacturing_practice\" target=\"_blank\" rel=\"wikipedia\">cGMP</a> pharmacy at your CRU for Phase I drug manufacturing yields benefits in quality and safety, timeline reduction and cost efficiency.</strong></h2>\n<p>The regulatory environment continues to move toward requiring drug manufacturing <a href=\"http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML.jpg\" rel=\"lightbox[3020]\" title=\"Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits\" class=\"cboxElement\"><img data-attachment-id=\"2985\" data-permalink=\"http://blog.covance.com/2017/01/important-early-considerations-for-assessing-drug-abuse-liability/49762929-pile-of-blue-pills-closeup/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML.jpg\" data-orig-size=\"1678,1119\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;49762929 - pile of blue pills, closeup&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;belchonock\\/123RF&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;49762929 - pile of blue pills, closeup&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"cGMP pharmacy Covance Blog\" data-image-description=\"<p>cGMP pharmacy Covance Blog</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-1024x683.jpg\" class=\"alignright size-medium wp-image-2985\" src=\"http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-300x200.jpg\" alt=\"cGMP pharmacy Covance Blog\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-1024x683.jpg 1024w, http://blog.covance.com/wp-content/uploads/2017/01/Drug-Dependency-Blog-Covance-Blue-Pills-49762929_ML-450x300.jpg 450w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>at current good manufacturing practice (cGMP)-compliant pharmacies. This trend and other factors make it increasingly attractive to use cGMP compounding on-site at your CRU for early development. Let’s look at <em>Three Big Benefits</em> for Phase I drug manufacturing:</p>\n<ol>\n<li>Quality and safety</li>\n<li>Timeline reduction</li>\n<li>Cost efficiency</li>\n</ol>\n<p> <a href=\"http://blog.covance.com/2017/03/phase-i-cgmp-drug-manufacture-at-the-cru/#more-3020\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F03%2Fphase-i-cgmp-drug-manufacture-at-the-cru%2F&amp;title=Phase+I+cGMP+Drug+Manufacture+at+the+CRU%3A+3+BIG+Benefits&amp;desc=Using+a+cGMP+pharmacy+at+your+CRU+for+Phase+I+drug+manufacturing+yields+benefits+in+quality+and+safety%2C+timeline+reduction+and+cost+efficiency.+The+regulatory+environment+continues+to+move+toward+requiring+drug+manufacturing+at+current+good+manufacturing+practice+%28cGMP%29-compliant+pharmacies.+This&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/clinical-development/\" rel=\"category tag\">Clinical Development</a>, <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/cgmp/\" rel=\"tag\">cGMP</a>, <a href=\"http://blog.covance.com/tag/clinical-research-unit/\" rel=\"tag\">clinical research unit</a>, <a href=\"http://blog.covance.com/tag/cru/\" rel=\"tag\">CRU</a>, <a href=\"http://blog.covance.com/tag/drug-development/\" rel=\"tag\">Drug Development</a>, <a href=\"http://blog.covance.com/tag/pharmacy/\" rel=\"tag\">Pharmacy</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3020 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3055\" class=\"post-3055 post type-post status-publish format-standard hentry category-clinical-development category-consulting category-drug-development category-health-economics-market-access tag-biosimilars tag-consulting tag-drug-development tag-fda tag-market-access tag-regulatory tag-webinar\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/03/the-biosimilars-landscape-what-all-developers-need-to-know/\" title=\"Permalink to The Biosimilars Landscape: What All Developers Need to Know\" rel=\"bookmark\">The Biosimilars Landscape: What All Developers Need to Know</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/covance/\" title=\"View all posts by Covance Inc.\" rel=\"author\">Covance Inc.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/03/the-biosimilars-landscape-what-all-developers-need-to-know/\" title=\"2:17 pm\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-03-16T14:17:40+00:00\" pubdate=\"\">Thursday, March 16, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>As biosimilars to treat rheumatic diseases begin get approval from the FDA, <a class=\"zem_slink\" title=\"Biosimilar\" href=\"http://en.wikipedia.org/wiki/Biosimilar\" target=\"_blank\" rel=\"wikipedia\">biosimilar</a> development remains a hot topic in drug development. Sponsors estimate <a href=\"http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar.jpg\" rel=\"lightbox[3055]\" title=\"The Biosimilars Landscape: What All Developers Need to Know\" class=\"cboxElement\"><img data-attachment-id=\"3060\" data-permalink=\"http://blog.covance.com/2017/03/the-biosimilars-landscape-what-all-developers-need-to-know/6359868-x-ray-hands-arthritis/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar.jpg\" data-orig-size=\"3750,5000\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;6359868 - x-ray hands - arthritis&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;eraxion\\/123RF&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;6359868 - x-ray hands - arthritis&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Covance Contract Research Org Biosimilars Webinar 2\" data-image-description=\"<p>Covance Contract Research Org Biosimilars Webinar 2</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar-225x300.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar-768x1024.jpg\" class=\"alignright wp-image-3060 size-medium\" src=\"http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar-225x300.jpg\" alt=\"Covance Contract Research Org Biosimilars Webinar 2\" width=\"225\" height=\"300\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar-225x300.jpg 225w, http://blog.covance.com/wp-content/uploads/2017/03/Covance-Biosimilars-Webinar-768x1024.jpg 768w\" sizes=\"(max-width: 225px) 100vw, 225px\"></a>a 35% growth of biosimilars in their development pipelines by 2020, but face a wide variety of regional and global markets along with shifting guidelines and recommendations, stressing the need to understand this rapidly changing landscape. What is the real potential for clinical and health-economic benefits offered by these agents?&nbsp; <a href=\"http://blog.covance.com/2017/03/the-biosimilars-landscape-what-all-developers-need-to-know/#more-3055\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F03%2Fthe-biosimilars-landscape-what-all-developers-need-to-know%2F&amp;title=The+Biosimilars+Landscape%3A+What+All+Developers+Need+to+Know&amp;desc=As+biosimilars+to+treat+rheumatic+diseases+begin+get+approval+from+the+FDA%2C+biosimilar+development+remains+a+hot+topic+in+drug+development.+Sponsors+estimate+a+35%25+growth+of+biosimilars+in+their+development+pipelines+by+2020%2C+but+face+a+wide+variety+of+regional+and+global+markets+along+with+shifting&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/clinical-development/\" rel=\"category tag\">Clinical Development</a>, <a href=\"http://blog.covance.com/drug-development/consulting/\" rel=\"category tag\">Consulting</a>, <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>, <a href=\"http://blog.covance.com/drug-development/health-economics-market-access/\" rel=\"category tag\">Health Economics &amp; Market Access</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/biosimilars/\" rel=\"tag\">biosimilars</a>, <a href=\"http://blog.covance.com/tag/consulting/\" rel=\"tag\">Consulting</a>, <a href=\"http://blog.covance.com/tag/drug-development/\" rel=\"tag\">Drug Development</a>, <a href=\"http://blog.covance.com/tag/fda/\" rel=\"tag\">FDA</a>, <a href=\"http://blog.covance.com/tag/market-access/\" rel=\"tag\">Market Access</a>, <a href=\"http://blog.covance.com/tag/regulatory/\" rel=\"tag\">Regulatory</a>, <a href=\"http://blog.covance.com/tag/webinar/\" rel=\"tag\">webinar</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3055 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3044\" class=\"post-3044 post type-post status-publish format-standard hentry category-drug-development tag-biomarkers tag-clinical-trials tag-companion-diagnostics tag-covance tag-immunotherapeutic-development tag-oncology tag-precision-medicine\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/02/precision-medicine-in-immuno-oncology/\" title=\"Permalink to Precision Medicine in Immuno-Oncology\" rel=\"bookmark\">Precision Medicine in Immuno-Oncology</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/susoplatero/\" title=\"View all posts by Suso Platero, Ph.D.\" rel=\"author\">Suso Platero, Ph.D.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/02/precision-medicine-in-immuno-oncology/\" title=\"1:39 pm\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-02-28T13:39:56+00:00\" pubdate=\"\">Tuesday, February 28, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>The NIH defines precision medicine as “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person<sup>1</sup>.” In cancer patients, we can rephrase the definition to “through detailed understanding of a cancer’s biology, providing the right drug, for the right patient, at the right time.”&nbsp;<a href=\"http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog.jpg\" rel=\"lightbox[3044]\" title=\"Precision Medicine in Immuno-Oncology\" class=\"cboxElement\"><img data-attachment-id=\"3051\" data-permalink=\"http://blog.covance.com/2017/02/precision-medicine-in-immuno-oncology/33192602-laboratory-microscope-lens-microscope-lens/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog.jpg\" data-orig-size=\"2508,1672\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;33192602 - laboratory microscope lens. microscope lens.&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;alex011973\\/123RF&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;33192602 - laboratory microscope lens. microscope lens.&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"33192602 – laboratory microscope lens. microscope lens.\" data-image-description=\"<p>Covance CRO Labs Blog</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog-1024x683.jpg\" class=\"alignright size-full wp-image-3051\" src=\"http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog.jpg\" alt=\"Covance CRO Labs Blog\" width=\"2508\" height=\"1672\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog.jpg 2508w, http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog-1024x683.jpg 1024w, http://blog.covance.com/wp-content/uploads/2017/02/Precision-Medicine-Covance-CRO-Blog-450x300.jpg 450w\" sizes=\"(max-width: 2508px) 100vw, 2508px\"></a></p>\n<p>In order to identify the correct drug, biomarkers are used to identify patients that can be treated with the appropriate therapy for their cancer. The FDA defines biomarkers as “a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions<sup>2</sup>.” Great strides have been made in the discovery and validation of biomarkers in drug development. <a href=\"http://blog.covance.com/2017/02/precision-medicine-in-immuno-oncology/#more-3044\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F02%2Fprecision-medicine-in-immuno-oncology%2F&amp;title=Precision+Medicine+in+Immuno-Oncology&amp;desc=The+NIH+defines+precision+medicine+as+%E2%80%9Can+emerging+approach+for+disease+treatment+and+prevention+that+takes+into+account+individual+variability+in+genes%2C+environment%2C+and+lifestyle+for+each+person1.%E2%80%9D+In+cancer+patients%2C+we+can+rephrase+the+definition+to+%E2%80%9Cthrough+detailed+understanding+of+a&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/biomarkers/\" rel=\"tag\">Biomarkers</a>, <a href=\"http://blog.covance.com/tag/clinical-trials/\" rel=\"tag\">clinical trials</a>, <a href=\"http://blog.covance.com/tag/companion-diagnostics/\" rel=\"tag\">Companion Diagnostics</a>, <a href=\"http://blog.covance.com/tag/covance/\" rel=\"tag\">Covance</a>, <a href=\"http://blog.covance.com/tag/immunotherapeutic-development/\" rel=\"tag\">immunotherapeutic development</a>, <a href=\"http://blog.covance.com/tag/oncology/\" rel=\"tag\">Oncology</a>, <a href=\"http://blog.covance.com/tag/precision-medicine/\" rel=\"tag\">precision medicine</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3044 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-3025\" class=\"post-3025 post type-post status-publish format-standard hentry category-drug-development tag-animal-testing-alternatives tag-are-nrf2-luciferase tag-dpra tag-h-clat tag-in-vitro-skin-sensitization tag-keratinosens tag-reach\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/02/reach-a-better-solution-in-vitro-skin-sensitization-assays-as-animal-testing-alternatives/\" title=\"Permalink to REACH a Better Solution: in vitro Skin Sensitization Assays as Animal Testing Alternatives\" rel=\"bookmark\">REACH a Better Solution: in vitro Skin Sensitization Assays as Animal Testing Alternatives</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/kiddrothwellhenderson/\" title=\"View all posts by Darren Kidd, PhD, Chris Rothwell, BSc, Debbie Henderson, BSc\" rel=\"author\">Darren Kidd, PhD, Chris Rothwell, BSc, Debbie Henderson, BSc</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/02/reach-a-better-solution-in-vitro-skin-sensitization-assays-as-animal-testing-alternatives/\" title=\"11:57 am\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-02-27T11:57:35+00:00\" pubdate=\"\">Monday, February 27, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<h2><strong>REACH a Better Solution: <em>in vitro</em> Skin Sensitization Assays as Animal Testing <a href=\"http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1.jpg\" rel=\"lightbox[3025]\" title=\"REACH a Better Solution: in vitro Skin Sensitization Assays as Animal Testing Alternatives\" class=\"cboxElement\"><img data-attachment-id=\"3035\" data-permalink=\"http://blog.covance.com/2017/02/reach-a-better-solution-in-vitro-skin-sensitization-assays-as-animal-testing-alternatives/skin-sensitisation-assay-covance-blog-2/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1.jpg\" data-orig-size=\"1000,1000\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Skin Sensitisation Assay Covance Blog\" data-image-description=\"\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1-300x300.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1.jpg\" class=\"alignright wp-image-3035 size-medium\" src=\"http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1-300x300.jpg\" width=\"300\" height=\"300\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1-300x300.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1-150x150.jpg 150w, http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1-768x768.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/02/Skin-Sensitisation-Assay-Covance-Blog-1.jpg 1000w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>Alternatives</strong></h2>\n<p>Skin sensitization testing is a major gap for many companies addressing the 2018 REACH substance registration deadline. Join us for a Q&amp;A session with our Covance experts as we review REACH requirements and focus on a better solution for skin sensitization studies: <em>in vitro</em> assays as new alternatives to animal testing.</p>\n<h2>Q: What do REACH regulations hope to achieve?</h2>\n<p>A: The European Regulation on <a class=\"zem_slink\" title=\"Registration, Evaluation, Authorisation and Restriction of Chemicals\" href=\"http://en.wikipedia.org/wiki/Registration%2C_Evaluation%2C_Authorisation_and_Restriction_of_Chemicals\" target=\"_blank\" rel=\"wikipedia\">Registration, Evaluation, Authorization and Restriction of Chemicals</a> (REACH) places responsibility on companies to assess and manage risks posed by chemicals. They also have to provide appropriate safety information to users. The first purpose is to ensure protection of human health and the environment. Next, the regulation promotes using alternatives to animal test methods. Third, it seeks free circulation of substances to the market, with enhanced competitiveness and innovation. <a href=\"http://blog.covance.com/2017/02/reach-a-better-solution-in-vitro-skin-sensitization-assays-as-animal-testing-alternatives/#more-3025\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F02%2Freach-a-better-solution-in-vitro-skin-sensitization-assays-as-animal-testing-alternatives%2F&amp;title=REACH+a+Better+Solution%3A+in+vitro+Skin+Sensitization+Assays+as+Animal+Testing+Alternatives&amp;desc=REACH+a+Better+Solution%3A+in+vitro+Skin+Sensitization+Assays+as+Animal+Testing+Alternatives+Skin+sensitization+testing+is+a+major+gap+for+many+companies+addressing+the+2018+REACH+substance+registration+deadline.+Join+us+for+a+Q%26amp%3Bamp%3BA+session+with+our+Covance+experts+as+we+review+REACH+requirements&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/animal-testing-alternatives/\" rel=\"tag\">Animal testing alternatives</a>, <a href=\"http://blog.covance.com/tag/are-nrf2-luciferase/\" rel=\"tag\">ARE-Nrf2 luciferase</a>, <a href=\"http://blog.covance.com/tag/dpra/\" rel=\"tag\">DPRA</a>, <a href=\"http://blog.covance.com/tag/h-clat/\" rel=\"tag\">h-CLAT</a>, <a href=\"http://blog.covance.com/tag/in-vitro-skin-sensitization/\" rel=\"tag\">in vitro skin sensitization</a>, <a href=\"http://blog.covance.com/tag/keratinosens/\" rel=\"tag\">KeratinoSens</a>, <a href=\"http://blog.covance.com/tag/reach/\" rel=\"tag\">REACH</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-3025 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-2953\" class=\"post-2953 post type-post status-publish format-standard hentry category-careers tag-careers tag-cra\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/02/keeping-skills-sharp-cras/\" title=\"Permalink to Keeping Skills Sharp For CRAs\" rel=\"bookmark\">Keeping Skills Sharp For CRAs</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/covance/\" title=\"View all posts by Covance Inc.\" rel=\"author\">Covance Inc.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/02/keeping-skills-sharp-cras/\" title=\"1:01 pm\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-02-01T13:01:14+00:00\" pubdate=\"\">Wednesday, February 1, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>The drug industry is evolving and clinical trials are becoming more complex. How do CRAs in a large global company keep their skills up to date? Recognizing that large group meetings are costly and virtual training feels impersonal, <a class=\"zem_slink\" title=\"Covance\" href=\"http://www.covance.com/\" target=\"_blank\" rel=\"homepage\">Covance</a> decided to address this challenge with an innovative model called CLIK: Country Leadership Imparting Knowledge.<a href=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog.jpg\" rel=\"lightbox[2953]\" title=\"Keeping Skills Sharp For CRAs\" class=\"cboxElement\"><img data-attachment-id=\"2954\" data-permalink=\"http://blog.covance.com/2017/02/keeping-skills-sharp-cras/covance-employees-cra-careers-blog/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog.jpg\" data-orig-size=\"960,640\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"covance-employees-cra-careers-blog\" data-image-description=\"<p>Covance CRA Careers </p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog.jpg\" class=\"alignright size-medium wp-image-2954\" src=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog-300x200.jpg\" alt=\"Covance CRA Careers\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog-450x300.jpg 450w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Employees-CRA-Careers-Blog.jpg 960w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a></p>\n<p>With selected leaders identified from each of the 70+ countries that Covance serves, the CLIK program brings CRAs face-to-face to share their experiences, gain new knowledge and then serve as training representatives for peers in their own regional teams. <a href=\"http://blog.covance.com/2017/02/keeping-skills-sharp-cras/#more-2953\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F02%2Fkeeping-skills-sharp-cras%2F&amp;title=Keeping+Skills+Sharp+For+CRAs&amp;desc=The+drug+industry+is+evolving+and+clinical+trials+are+becoming+more+complex.+How+do+CRAs+in+a+large+global+company+keep+their+skills+up+to+date%3F+Recognizing+that+large+group+meetings+are+costly+and+virtual+training+feels+impersonal%2C+Covance+decided+to+address+this+challenge+with+an+innovative+model&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/careers/\" rel=\"category tag\">Careers</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/careers/\" rel=\"tag\">Careers</a>, <a href=\"http://blog.covance.com/tag/cra/\" rel=\"tag\">CRA</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-2953 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-2988\" class=\"post-2988 post type-post status-publish format-standard hentry category-clinical-development category-drug-development category-safety-assessment tag-drug-abuse tag-drug-development tag-drug-safety tag-fda tag-opioid\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/01/understanding-regulatory-and-market-access-considerations-with-drug-abuse-potential/\" title=\"Permalink to Understanding Regulatory and Market Access Considerations With Drug Abuse Potential\" rel=\"bookmark\">Understanding Regulatory and Market Access Considerations With Drug Abuse Potential</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/covance/\" title=\"View all posts by Covance Inc.\" rel=\"author\">Covance Inc.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/01/understanding-regulatory-and-market-access-considerations-with-drug-abuse-potential/\" title=\"9:00 am\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-01-19T09:00:28+00:00\" pubdate=\"\">Thursday, January 19, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>Each assessment for abuse liability is as unique as the molecule in question, reiterating <a href=\"http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog.jpg\" rel=\"lightbox[2988]\" title=\"Understanding Regulatory and Market Access Considerations With Drug Abuse Potential\" class=\"cboxElement\"><img data-attachment-id=\"2997\" data-permalink=\"http://blog.covance.com/2017/01/understanding-regulatory-and-market-access-considerations-with-drug-abuse-potential/10506792-pill-bottle-with-white-pills-on-a-white-background/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog.jpg\" data-orig-size=\"2508,1672\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;10506792 - pill bottle with white pills on a white background.&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;hotwalkn\\/123RF&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;10506792 - pill bottle with white pills on a white background.&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Regulatory And Market Access Considerations With Drug Abuse Potential\" data-image-description=\"<p>Regulatory And Market Access Considerations With Drug Abuse Potential</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-1024x683.jpg\" class=\"alignright wp-image-2997 size-medium\" src=\"http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-300x200.jpg\" alt=\"Regulatory And Market Access Considerations With Drug Abuse Potential\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-768x512.jpg 768w, http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-1024x683.jpg 1024w, http://blog.covance.com/wp-content/uploads/2017/01/Pills-Covance-Blog-450x300.jpg 450w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>the importance of early awareness, understanding the current regulatory landscape, and being able to plan your development and post-marketing accordingly.</p>\n<p>In our <a href=\"http://wp.me/p3q40m-M6\">previous blog post</a>, we focused on the value of early drug abuse potential testing. In this blog, we’ll delve into important regulatory and market access considerations for abuse liability testing that can help drug developers maximize the potential of their molecule.</p>\n<p> <a href=\"http://blog.covance.com/2017/01/understanding-regulatory-and-market-access-considerations-with-drug-abuse-potential/#more-2988\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F01%2Funderstanding-regulatory-and-market-access-considerations-with-drug-abuse-potential%2F&amp;title=Understanding+Regulatory+and+Market+Access+Considerations+With+Drug+Abuse+Potential&amp;desc=Each+assessment+for+abuse+liability+is+as+unique+as+the+molecule+in+question%2C+reiterating+the+importance+of+early+awareness%2C+understanding+the+current+regulatory+landscape%2C+and+being+able+to+plan+your+development+and+post-marketing+accordingly.+In+our+previous+blog+post%2C+we+focused+on+the+value+of&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/clinical-development/\" rel=\"category tag\">Clinical Development</a>, <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>, <a href=\"http://blog.covance.com/drug-development/safety-assessment/\" rel=\"category tag\">Safety Assessment</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/drug-abuse/\" rel=\"tag\">Drug Abuse</a>, <a href=\"http://blog.covance.com/tag/drug-development/\" rel=\"tag\">Drug Development</a>, <a href=\"http://blog.covance.com/tag/drug-safety/\" rel=\"tag\">Drug Safety</a>, <a href=\"http://blog.covance.com/tag/fda/\" rel=\"tag\">FDA</a>, <a href=\"http://blog.covance.com/tag/opioid/\" rel=\"tag\">Opioid</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-2988 -->\n\n\t\t\t\t\n\t\t\t\t\t\n\t<article id=\"post-2957\" class=\"post-2957 post type-post status-publish format-standard hentry category-central-laboratory-services category-drug-development tag-clinical-research-studies tag-clinical-trials tag-drug-development\">\n\t\t<header class=\"entry-header\">\n\t\t\t\t\t\t<h1 class=\"entry-title\"><a href=\"http://blog.covance.com/2017/01/clinical-trial-investigator-sites/\" title=\"Permalink to Getting Investigators Onboard:  Lab Preferences Make a Difference in Trial Participation\" rel=\"bookmark\">Getting Investigators Onboard:  Lab Preferences Make a Difference in Trial Participation</a></h1>\n\t\t\t\n\t\t\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t<span class=\"by-author\"> <span class=\"sep\">Posted by </span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"http://blog.covance.com/author/covance/\" title=\"View all posts by Covance Inc.\" rel=\"author\">Covance Inc.</a></span></span><br><span class=\"sep\"></span><a href=\"http://blog.covance.com/2017/01/clinical-trial-investigator-sites/\" title=\"9:00 am\" rel=\"bookmark\"><time class=\"entry-date\" datetime=\"2017-01-17T09:00:59+00:00\" pubdate=\"\">Tuesday, January 17, 2017</time></a>\t\t\t</div><!-- .entry-meta -->\n\t\t\t\n\t\t\t\t\t</header><!-- .entry-header -->\n\n\t\t\t\t<div class=\"entry-content\">\n\t\t\t<p>Clinical trials are becoming increasingly complex and competitive, so attracting the best investigator sites to participate in a trial is a crucial step in meeting patient enrollment targets.</p>\n<p>Delaying approval by even one day can cost hundreds of thousands of dollars or more, <a href=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post.jpg\" rel=\"lightbox[2957]\" title=\"Getting Investigators Onboard:  Lab Preferences Make a Difference in Trial Participation\" class=\"cboxElement\"><img data-attachment-id=\"2958\" data-permalink=\"http://blog.covance.com/2017/01/clinical-trial-investigator-sites/covance-clinical-trials-blog-post/\" data-orig-file=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post.jpg\" data-orig-size=\"1503,1000\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"covance-clinical-trials-blog-post\" data-image-description=\"<p>Covance Labs Clinical Trial Participation</p>\" data-medium-file=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-300x200.jpg\" data-large-file=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-1024x681.jpg\" class=\"alignright size-medium wp-image-2958\" src=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-300x200.jpg\" alt=\"Covance Labs Clinical Trial Participation\" width=\"300\" height=\"200\" srcset=\"http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-300x200.jpg 300w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-768x511.jpg 768w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-1024x681.jpg 1024w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post-451x300.jpg 451w, http://blog.covance.com/wp-content/uploads/2016/11/Covance-Clinical-Trials-Blog-Post.jpg 1503w\" sizes=\"(max-width: 300px) 100vw, 300px\"></a>depending on the drug. This means that timely trial implementation, including patient enrollment, may add significant value.</p>\n<p>Meeting patient enrollment milestones in cooperation with investigators has traditionally been viewed as the responsibility of the contract research organization (CRO). Now, important new data show that a sponsor’s choice of a central lab impacts the willingness of investigators to work with a sponsor on clinical trials. <a href=\"http://blog.covance.com/2017/01/clinical-trial-investigator-sites/#more-2957\" class=\"more-link\">Continue reading <span class=\"meta-nav\">→</span></a></p>\n<div style=\"padding-top:5px;padding-right:0px;padding-bottom:5px;padding-left:0px;;\" class=\"linksalpha_widget\">\n\t\t\t\t\t\t\t\t\t\t\t<iframe style=\"height:25px !important; border:0px solid gray !important; overflow:hidden !important; width:550px !important;\" frameborder=\"0\" scrolling=\"no\" allowtransparency=\"true\" src=\"http://www.linksalpha.com/social?blog=Covance+Blog&amp;link=http%3A%2F%2Fblog.covance.com%2F2017%2F01%2Fclinical-trial-investigator-sites%2F&amp;title=Getting+Investigators+Onboard%3A+Lab+Preferences+Make+a+Difference+in+Trial+Participation&amp;desc=Clinical+trials+are+becoming+increasingly+complex+and+competitive%2C+so+attracting+the+best+investigator+sites+to+participate+in+a+trial+is+a+crucial+step+in+meeting+patient+enrollment+targets.+Delaying+approval+by+even+one+day+can+cost+hundreds+of+thousands+of+dollars+or+more%2C+depending+on+the+drug.&amp;fc=333333&amp;fs=arial&amp;fblname=like&amp;fblref=facebook&amp;fbllang=en_US&amp;fblshow=1&amp;fbsbutton=1&amp;fbsctr=1&amp;fbslang=en&amp;fbsendbutton=0&amp;twbutton=1&amp;twlang=en&amp;twmention=covance&amp;twrelated1=covance&amp;twrelated2=&amp;twctr=1&amp;lnkdshow=show&amp;lnkdctr=1&amp;buzzbutton=0&amp;buzzlang=en&amp;buzzctr=0&amp;diggbutton=1&amp;diggctr=1&amp;stblbutton=1&amp;stblctr=1&amp;g1button=1&amp;g1ctr=1&amp;g1lang=en-US\">\n\t\t\t\t\t\t\t\t\t\t\t</iframe>\n\t\t\t\t\t\t\t\t\t\t</div>\t\t\t\t\t</div><!-- .entry-content -->\n\t\t\n\t\t<footer class=\"entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cat-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-cat-links\">Posted in</span> <a href=\"http://blog.covance.com/drug-development/central-laboratory-services/\" rel=\"category tag\">Clinical Testing</a>, <a href=\"http://blog.covance.com/drug-development/\" rel=\"category tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\t\t\t<span class=\"sep\"> | </span>\n\t\t\t\t\t\t\t<span class=\"tag-links\">\n\t\t\t\t<span class=\"entry-utility-prep entry-utility-prep-tag-links\">Tagged</span> <a href=\"http://blog.covance.com/tag/clinical-research-studies/\" rel=\"tag\">clinical research studies</a>, <a href=\"http://blog.covance.com/tag/clinical-trials/\" rel=\"tag\">clinical trials</a>, <a href=\"http://blog.covance.com/tag/drug-development/\" rel=\"tag\">Drug Development</a>\t\t\t</span>\n\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t</footer><!-- #entry-meta -->\n\t</article><!-- #post-2957 -->\n\n\t\t\t\t\n\t\t\t\t\t\t<nav id=\"nav-below\">\n\t\t\t<h3 class=\"assistive-text\">Post navigation</h3>\n\t\t\t<div class=\"nav-previous\"><a href=\"http://blog.covance.com/page/2/\"><span class=\"meta-nav\">←</span> Older posts</a></div>\n\t\t\t<div class=\"nav-next\"></div>\n\t\t</nav><!-- #nav-above -->\n\t\n\t\t\t\n\t\t\t</div><!-- #content -->\n\t\t</div><!-- #primary -->\n\n\t\t<div id=\"secondary\" class=\"widget-area\" role=\"complementary\">\n\t\t\t<aside id=\"text-2\" class=\"widget widget_text\">\t\t\t<div class=\"textwidget\"><p><a href=\"http://feeds.feedburner.com/CovanceBlog\" rel=\"alternate\" type=\"application/rss+xml\"><img src=\"http://www.feedburner.com/fb/images/pub/feed-icon16x16.png\" alt=\"\" style=\"vertical-align:middle;border:0\"></a>&nbsp;<a href=\"http://feeds.feedburner.com/CovanceBlog\" rel=\"alternate\" type=\"application/rss+xml\"> Subscribe in a reader</a></p></div>\n\t\t</aside><aside id=\"nav_menu-3\" class=\"widget widget_nav_menu\"><h3 class=\"widget-title\">Languages:</h3><div class=\"menu-languages-container\"><ul id=\"menu-languages\" class=\"menu\"><li id=\"menu-item-2536\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2536\"><a href=\"http://zh.covance.com/sdblog/dcovance/\">简体中文</a></li>\n<li id=\"menu-item-2537\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2537\"><a href=\"http://fr.covance.com/sdblog/dcovance/\">Français</a></li>\n<li id=\"menu-item-2538\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2538\"><a href=\"http://de.covance.com/sdblog/dcovance/\">Deutsch</a></li>\n<li id=\"menu-item-2539\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2539\"><a href=\"http://ja.covance.com/sdblog/dcovance/\">日本語</a></li>\n<li id=\"menu-item-2540\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2540\"><a href=\"http://es.covance.com/sdblog/dcovance/\">Español</a></li>\n<li id=\"menu-item-2543\" class=\"menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home menu-item-2543\"><a href=\"http://blog.covance.com\">English</a></li>\n</ul></div></aside><aside id=\"search-2\" class=\"widget widget_search\">\t<form method=\"get\" id=\"searchform\" action=\"http://blog.covance.com/\">\n\t\t<label for=\"s\" class=\"assistive-text\">Search</label>\n\t\t<input type=\"text\" class=\"field\" name=\"s\" id=\"s\" placeholder=\"Search\">\n\t\t<input type=\"submit\" class=\"submit\" name=\"submit\" id=\"searchsubmit\" value=\"Search\">\n\t</form>\n</aside><aside id=\"widget_sp_image-3\" class=\"widget widget_sp_image\"><h3 class=\"widget-title\">Inflammation eBook </h3><a href=\"http://response.covance.com/LP=923?elqCampaignId=815&amp;cid=Bl_Dld_CLNLAT_Inflammation-ebook_1215_815%20%20\" id=\"\" target=\"_blank\" class=\"widget_sp_image-image-link\" title=\"Inflammation Clinical Trials eBook Covance Blog\" rel=\"\"><img width=\"160\" height=\"503\" alt=\"Inflammation Clinical Trials eBook Covance Blog\" class=\"attachment-full alignleft\" style=\"max-width: 100%;\" src=\"http://blog.covance.com/wp-content/uploads/2015/12/Inflammation-ebook-Covance-Blog.jpg\"></a></aside><aside id=\"archives-3\" class=\"widget widget_archive\"><h3 class=\"widget-title\">Archives</h3>\t\t<label class=\"screen-reader-text\" for=\"archives-dropdown-3\">Archives</label>\n\t\t<select id=\"archives-dropdown-3\" name=\"archive-dropdown\" onchange=\"document.location.href=this.options[this.selectedIndex].value;\">\n\t\t\t\n\t\t\t<option value=\"\">Select Month</option>\n\t\t\t\t<option value=\"http://blog.covance.com/2017/04/\"> April 2017 </option>\n\t<option value=\"http://blog.covance.com/2017/03/\"> March 2017 </option>\n\t<option value=\"http://blog.covance.com/2017/02/\"> February 2017 </option>\n\t<option value=\"http://blog.covance.com/2017/01/\"> January 2017 </option>\n\t<option value=\"http://blog.covance.com/2016/12/\"> December 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/11/\"> November 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/09/\"> September 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/08/\"> August 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/07/\"> July 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/06/\"> June 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/05/\"> May 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/04/\"> April 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/03/\"> March 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/02/\"> February 2016 </option>\n\t<option value=\"http://blog.covance.com/2016/01/\"> January 2016 </option>\n\t<option value=\"http://blog.covance.com/2015/12/\"> December 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/11/\"> November 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/10/\"> October 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/09/\"> September 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/08/\"> August 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/07/\"> July 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/06/\"> June 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/05/\"> May 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/04/\"> April 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/03/\"> March 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/02/\"> February 2015 </option>\n\t<option value=\"http://blog.covance.com/2015/01/\"> January 2015 </option>\n\t<option value=\"http://blog.covance.com/2014/12/\"> December 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/11/\"> November 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/10/\"> October 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/09/\"> September 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/08/\"> August 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/07/\"> July 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/06/\"> June 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/05/\"> May 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/04/\"> April 2014 </option>\n\t<option value=\"http://blog.covance.com/2014/03/\"> March 2014 </option>\n\t<option value=\"http://blog.covance.com/2013/12/\"> December 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/11/\"> November 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/10/\"> October 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/09/\"> September 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/08/\"> August 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/07/\"> July 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/06/\"> June 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/05/\"> May 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/04/\"> April 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/03/\"> March 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/02/\"> February 2013 </option>\n\t<option value=\"http://blog.covance.com/2013/01/\"> January 2013 </option>\n\t<option value=\"http://blog.covance.com/2012/12/\"> December 2012 </option>\n\t<option value=\"http://blog.covance.com/2012/11/\"> November 2012 </option>\n\t<option value=\"http://blog.covance.com/2012/10/\"> October 2012 </option>\n\t<option value=\"http://blog.covance.com/2012/09/\"> September 2012 </option>\n\n\t\t</select>\n\t\t</aside><aside id=\"categories-3\" class=\"widget widget_categories\"><h3 class=\"widget-title\">Categories</h3>\t\t<ul>\n\t<li class=\"cat-item cat-item-94\"><a href=\"http://blog.covance.com/drug-development/analytical-services/\">Analytical Services</a>\n</li>\n\t<li class=\"cat-item cat-item-286\"><a href=\"http://blog.covance.com/careers/\">Careers</a>\n</li>\n\t<li class=\"cat-item cat-item-11\"><a href=\"http://blog.covance.com/drug-development/clinical-development/\">Clinical Development</a>\n</li>\n\t<li class=\"cat-item cat-item-10\"><a href=\"http://blog.covance.com/drug-development/central-laboratory-services/\">Clinical Testing</a>\n</li>\n\t<li class=\"cat-item cat-item-180\"><a href=\"http://blog.covance.com/drug-development/consulting/\">Consulting</a>\n</li>\n\t<li class=\"cat-item cat-item-64\"><a href=\"http://blog.covance.com/drug-development/\">Drug Development</a>\n</li>\n\t<li class=\"cat-item cat-item-4\"><a href=\"http://blog.covance.com/foodsolutions/\">Food Solutions</a>\n</li>\n\t<li class=\"cat-item cat-item-181\"><a href=\"http://blog.covance.com/drug-development/health-economics-market-access/\">Health Economics &amp; Market Access</a>\n</li>\n\t<li class=\"cat-item cat-item-19\"><a href=\"http://blog.covance.com/healthcare/\">Healthcare</a>\n</li>\n\t<li class=\"cat-item cat-item-99\"><a href=\"http://blog.covance.com/drug-development/lead-optimization-drug-development/\">Lead Optimization</a>\n</li>\n\t<li class=\"cat-item cat-item-61\"><a href=\"http://blog.covance.com/drug-development/manufacturing-support/\">Manufacturing Support</a>\n</li>\n\t<li class=\"cat-item cat-item-238\"><a href=\"http://blog.covance.com/safety/\">Safety</a>\n</li>\n\t<li class=\"cat-item cat-item-179\"><a href=\"http://blog.covance.com/drug-development/safety-assessment/\">Safety Assessment</a>\n</li>\n\t<li class=\"cat-item cat-item-1\"><a href=\"http://blog.covance.com/uncategorized/\">Uncategorized</a>\n</li>\n\t\t</ul>\n</aside>\t\t<aside id=\"recent-posts-2\" class=\"widget widget_recent_entries\">\t\t<h3 class=\"widget-title\">Recent Posts</h3>\t\t<ul>\n\t\t\t\t\t<li>\n\t\t\t\t<a href=\"http://blog.covance.com/2017/04/measles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation/\">Stepping Up the Game: Measles, Mumps, Rubella and Varicella (MMRV) Concomitant Testing Support for Vaccine Evaluation</a>\n\t\t\t\t\t\t</li>\n\t\t\t\t\t<li>\n\t\t\t\t<a href=\"http://blog.covance.com/2017/04/hot-topics-discussed-in-covance-spring-webinars/\">Hot Topics Discussed in Covance Spring Webinars</a>\n\t\t\t\t\t\t</li>\n\t\t\t\t\t<li>\n\t\t\t\t<a href=\"http://blog.covance.com/2017/03/clinical-research-excellence-awards-shortlist-xcellerate-medical-review/\">Clinical &amp; Research Excellence Awards Shortlist Xcellerate Medical Review</a>\n\t\t\t\t\t\t</li>\n\t\t\t\t\t<li>\n\t\t\t\t<a href=\"http://blog.covance.com/2017/03/phase-i-cgmp-drug-manufacture-at-the-cru/\">Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits</a>\n\t\t\t\t\t\t</li>\n\t\t\t\t\t<li>\n\t\t\t\t<a href=\"http://blog.covance.com/2017/03/the-biosimilars-landscape-what-all-developers-need-to-know/\">The Biosimilars Landscape: What All Developers Need to Know</a>\n\t\t\t\t\t\t</li>\n\t\t\t\t</ul>\n\t\t</aside>\t\t<aside id=\"text-3\" class=\"widget widget_text\">\t\t\t<div class=\"textwidget\"><iframe id=\"twitter-widget-0\" scrolling=\"no\" frameborder=\"0\" allowtransparency=\"true\" allowfullscreen=\"true\" class=\"twitter-timeline twitter-timeline-rendered\" style=\"position: static; visibility: visible; display: inline-block; width: 520px; height: 1730.14px; padding: 0px; border: none; max-width: 100%; min-width: 180px; margin-top: 0px; margin-bottom: 0px;\" data-widget-id=\"479717329547165696\" title=\"Twitter Timeline\"></iframe>\n<script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+\"://platform.twitter.com/widgets.js\";fjs.parentNode.insertBefore(js,fjs);}}(document,\"script\",\"twitter-wjs\");</script></div>\n\t\t</aside>\t\t</div><!-- #secondary .widget-area -->\n\n\t</div><!-- #main -->\n\n\t<footer id=\"colophon\" role=\"contentinfo\">\n\n\t\t\t\n\n\t\t\t<div id=\"site-generator\">\n \t<div class=\"right\">Copyright © 2016 Covance Inc. All rights reserved.</div>\n\t\t\t</div>\n\t</footer><!-- #colophon -->\n</div><!-- #page -->\n\n<script type=\"text/javascript\">\n<!-- var s_account = 'covanceblog'; -->\n</script>\n<script type=\"text/javascript\" src=\"/code/s_code.js\"></script>\n<script type=\"text/javascript\"><!--\ns.pageName = 'Blog Home' //page name\ns.channel = 'Blog Home' //channel\ns.pageType = 'Blog Home' //page type\ns.prop1 = 'Blog Home' //traffic variable 1\ns.prop2 = '' //traffic variable 2\ns.prop3 = '' //traffic variable 3\ns.prop4= '' //traffic variable 4\ns.prop5= '' //traffic variable 5\ns.campaign= '' //campaign variable\ns.state= '' //user state\ns.zip= '' //user zip\ns.events= '' //user events\ns.products= '' //user products\ns.purchaseID= '' //purchase ID\ns.eVar0 = ''\ns.eVar1= '' //conversion variable 1\ns.eVar2= '' //conversion variable 2\ns.eVar3= '' //conversion variable 3\ns.eVar4= '' //conversion variable 4\ns.eVar5= '' //conversion variable 5\n/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/\nvar s_code=s.t();if(s_code)document.write(s_code) //omniture variable\n-->\n</script>\n\t<div style=\"display:none\">\n\t</div>\n<!-- Lightbox Plus Colorbox v2.7.2/1.5.9 - 2013.01.24 - Message: 0-->\n<script type=\"text/javascript\">\njQuery(document).ready(function($){\n  $(\"a[rel*=lightbox]\").colorbox({speed:350,initialWidth:\"300\",initialHeight:\"100\",opacity:0.8,loop:false,scrolling:false,escKey:false,arrowKey:false,top:false,right:false,bottom:false,left:false});\n});\n</script>\n<!--[if lte IE 8]>\n<link rel='stylesheet' id='jetpack-carousel-ie8fix-css'  href='http://blog.covance.com/wp-content/plugins/jetpack/modules/carousel/jetpack-carousel-ie8fix.css?ver=20121024' type='text/css' media='all' />\n<![endif]-->\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/ubermenu/js/hoverIntent.js?ver=4.7.2\"></script>\n<script type=\"text/javascript\">\n/* <![CDATA[ */\nvar uberMenuSettings = {\"speed\":\"300\",\"trigger\":\"hoverIntent\",\"orientation\":\"horizontal\",\"transition\":\"slide\",\"hoverInterval\":\"20\",\"hoverTimeout\":\"400\",\"removeConflicts\":\"on\",\"autoAlign\":\"off\",\"noconflict\":\"off\",\"fullWidthSubs\":\"off\",\"androidClick\":\"on\",\"loadGoogleMaps\":\"off\"};\n/* ]]> */\n</script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/ubermenu/js/ubermenu.min.js?ver=4.7.2\"></script>\n<script type=\"text/javascript\" src=\"http://s0.wp.com/wp-content/js/devicepx-jetpack.js?ver=201716\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/lightbox-plus/js/jquery.colorbox.1.5.9-min.js?ver=1.5.9\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-includes/js/wp-embed.min.js?ver=4.7.2\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/jetpack/_inc/spin.js?ver=1.3\"></script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/jetpack/_inc/jquery.spin.js?ver=1.3\"></script>\n<script type=\"text/javascript\">\n/* <![CDATA[ */\nvar jetpackCarouselStrings = {\"widths\":[370,700,1000,1200,1400,2000],\"is_logged_in\":\"\",\"lang\":\"en\",\"ajaxurl\":\"http:\\/\\/blog.covance.com\\/wp-admin\\/admin-ajax.php\",\"nonce\":\"83a204b7fc\",\"display_exif\":\"1\",\"display_geo\":\"1\",\"single_image_gallery\":\"1\",\"single_image_gallery_media_file\":\"\",\"background_color\":\"black\",\"comment\":\"Comment\",\"post_comment\":\"Post Comment\",\"write_comment\":\"Write a Comment...\",\"loading_comments\":\"Loading Comments...\",\"download_original\":\"View full size <span class=\\\"photo-size\\\">{0}<span class=\\\"photo-size-times\\\">\\u00d7<\\/span>{1}<\\/span>\",\"no_comment_text\":\"Please be sure to submit some text with your comment.\",\"no_comment_email\":\"Please provide an email address to comment.\",\"no_comment_author\":\"Please provide your name to comment.\",\"comment_post_error\":\"Sorry, but there was an error posting your comment. Please try again later.\",\"comment_approved\":\"Your comment was approved.\",\"comment_unapproved\":\"Your comment is in moderation.\",\"camera\":\"Camera\",\"aperture\":\"Aperture\",\"shutter_speed\":\"Shutter Speed\",\"focal_length\":\"Focal Length\",\"comment_registration\":\"1\",\"require_name_email\":\"1\",\"login_url\":\"http:\\/\\/blog.covance.com\\/wp-login.php?redirect_to=http%3A%2F%2Fblog.covance.com%2F2017%2F04%2Fmeasles-mumps-rubella-and-varicella-mmrv-concomitant-testing-support-for-vaccine-evaluation%2F\",\"blog_id\":\"1\",\"local_comments_commenting_as\":\"<p id=\\\"jp-carousel-commenting-as\\\">You must be <a href=\\\"#\\\" class=\\\"jp-carousel-comment-login\\\">logged in<\\/a> to post a comment.<\\/p>\"};\n/* ]]> */\n</script>\n<script type=\"text/javascript\" src=\"http://blog.covance.com/wp-content/plugins/jetpack/modules/carousel/jetpack-carousel.js?ver=20160325\"></script>\n<script type=\"text/javascript\" src=\"http://stats.wp.com/e-201716.js\" async=\"\" defer=\"\"></script>\n<script type=\"text/javascript\">\n\t_stq = window._stq || [];\n\t_stq.push([ 'view', {v:'ext',j:'1:4.5',blog:'50540934',post:'0',tz:'-4',srv:'blog.covance.com'} ]);\n\t_stq.push([ 'clickTrackerInit', '50540934', '0' ]);\n</script>\n\n<script type=\"text/javascript\">\nif(typeof _satellite !== \"undefined\"){\n  _satellite.pageBottom();\n}\n</script>\n\n<meta name=\"google-site-verification\" content=\"qb754GsNQwFNfhsYIZlfF9Bazg_D-A2iQicI5v3jkNA\">\n<div id=\"tiptip_holder\" style=\"max-width:200px;\"><div id=\"tiptip_arrow\"><div id=\"tiptip_arrow_inner\"></div></div><div id=\"tiptip_content\"></div></div><div id=\"cboxOverlay\" style=\"display: none;\"></div><div id=\"colorbox\" class=\"\" role=\"dialog\" tabindex=\"-1\" style=\"display: none;\"><div id=\"cboxWrapper\"><div><div id=\"cboxTopLeft\" style=\"float: left;\"></div><div id=\"cboxTopCenter\" style=\"float: left;\"></div><div id=\"cboxTopRight\" style=\"float: left;\"></div></div><div style=\"clear: left;\"><div id=\"cboxMiddleLeft\" style=\"float: left;\"></div><div id=\"cboxContent\" style=\"float: left;\"><div id=\"cboxTitle\" style=\"float: left;\"></div><div id=\"cboxCurrent\" style=\"float: left;\"></div><button type=\"button\" id=\"cboxPrevious\"></button><button type=\"button\" id=\"cboxNext\"></button><button id=\"cboxSlideshow\"></button><div id=\"cboxLoadingOverlay\" style=\"float: left;\"></div><div id=\"cboxLoadingGraphic\" style=\"float: left;\"></div></div><div id=\"cboxMiddleRight\" style=\"float: left;\"></div></div><div style=\"clear: left;\"><div id=\"cboxBottomLeft\" style=\"float: left;\"></div><div id=\"cboxBottomCenter\" style=\"float: left;\"></div><div id=\"cboxBottomRight\" style=\"float: left;\"></div></div></div><div style=\"position: absolute; width: 9999px; visibility: hidden; display: none; max-width: none;\"></div></div><div><iframe height=\"0\" width=\"0\" frameborder=\"0\" id=\"linksalpha_info_loader\" src=\"//www.linksalpha.com/social/info_3?v=2&amp;title=Covance%20Blog%20-%20Sharing%20Innovation%20in%20Drug%20Development&amp;link=http%3A%2F%2Fblog.covance.com%2F\"></iframe></div><script id=\"PIN_1492933324309.f.callback[0]\" type=\"text/javascript\" charset=\"utf-8\" src=\"https://log.pinterest.com/?guid=W8VCd7mQkE8g&amp;tv=2017042001&amp;type=pidget&amp;sub=www&amp;button_count=0&amp;follow_count=0&amp;pin_count=0&amp;profile_count=0&amp;board_count=0&amp;lang=en&amp;via=http%3A%2F%2Fblog.covance.com%2F&amp;callback=PIN_1492933324309.f.callback[0]\"></script><iframe id=\"rufous-sandbox\" scrolling=\"no\" frameborder=\"0\" allowtransparency=\"true\" allowfullscreen=\"true\" style=\"position: absolute; visibility: hidden; display: none; width: 0px; height: 0px; padding: 0px; border: none;\" title=\"Twitter analytics iframe\"></iframe></body>"}
